Somatoform disorder

F5_SOMATOFORM

somatoform disorder: A category of psychiatric disorders which are characterized by the presence of physical symptoms that suggest a medical condition but are not fully explained by any known medical reasons. [database_cross_reference: NCIT:C34956]

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F45 Hospital discharge: ICD-9 — 3008\|3007 Hospital discharge: ICD-8 — 305 Cause of death: ICD-10 — F45 Cause of death: ICD-9 — 3008\|3007 Cause of death: ICD-8 — 305 2 out of 7 registries used, show all original rules.	8615
4. Check minimum number of events None	8615
5. Include endpoints None	8615
6. Filter based on genotype QC (FinnGen only)	7721

Control definitions (FinnGen only)

Control exclude: F5_NEUROTIC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F40-F48
Name in latin: Perturbationes somatoformes

NAME	F5_SOMATOFORM
CONTROL_EXCLUDE	F5_NEUROTIC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F45
HD_ICD_9	3008\|3007
HD_ICD_8	305
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F45
COD_ICD_9	3008\|3007
COD_ICD_8	305
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Somatoform disorder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Bruxism

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	50413	32373	17694
Only index persons	46475	30344	16131
Unadjusted period prevalence (%)
Whole population	0.77	0.93	0.49
Only index persons	0.94	1.12	0.62
Median age at first event (years)
Whole population	44.83	46.21	42.32
Only index persons	44.11	45.46	41.56

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7721	5494	2227
Unadjusted period prevalence (%)	1.68	1.95	1.02
Median age at first event (years)	46.89	46.37	48.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8039: Matched controls
80390

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

7.8

321.0

459

622

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

8.7

320.7

415

499

A02BC01

ATC

omeprazole; systemic

2.6

320.0

2712

13262

N05BE01

ATC

buspirone; oral

8.9

317.6

405

478

N06AX26

ATC

vortioxetine; oral

4.1

316.4

975

2648

R53

ICD-10 Finland

Malaise and fatigue

2.6

313.8

2689

13197

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.0

311.8

1714

6704

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

19.4

310.6

243

129

R42

ICD-10 Finland

Dizziness and giddiness

2.6

309.2

2356

10915

N05BA04

ATC

oxazepam; oral

3.6

307.7

2982

11425

N05CF01

ATC

zopiclone; oral

2.6

307.7

2950

14790

N03AX09

ATC

lamotrigine; oral

8.0

307.7

919

1277

F61.0

ICD-10 Finland

Mixed personality disorders

15.2

307.7

293

200

F41.1

ICD-10 Finland

Generalized anxiety disorder

9.2

307.7

848

1014

R51.80

ICD-10 Finland

Headache

3.7

307.7

2326

8006

F43.1

ICD-10 Finland

Post-traumatic stress disorder

12.6

307.7

439

366

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

4.8

307.7

2051

5347

N02AX02

ATC

tramadol; systemic, rectal

3.0

307.7

4376

23108

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

6.3

307.7

1508

2851

N06AB03

ATC

fluoxetine; oral

3.7

307.7

1418

4383

N05BA12

ATC

alprazolam; oral

4.0

307.7

1166

3249

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.1

307.7

4281

21646

G44.2

ICD-10 Finland

Tension-type headache

3.7

307.7

2060

6853

N06AX21

ATC

duloxetine; oral

6.8

307.7

2380

4685

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

5.9

307.7

1285

2530

F32.9

ICD-10 Finland

Depressive episode, unspecified

5.3

307.7

1983

4645

M79.0

ICD-10 Finland

Rheumatism, unspecified

8.1

307.7

758

1021

M79.1

ICD-10 Finland

Myalgia

4.1

307.7

2388

7505

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

7.7

307.7

925

1330

G50.1

ICD-10 Finland

Atypical facial pain

9.7

307.7

463

501

N02BF02

ATC

pregabalin; oral

4.2

307.7

960

2515

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

5.5

307.7

1530

3280

C07AA05

ATC

propranolol; systemic

3.0

307.7

2309

9490

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.5

307.7

1262

3220

A01

ICPC

Pain general/multiple sites

4.2

307.7

1472

4109

F45.1

ICD-10 Finland

Undifferentiated somatoform disorder

62.8

307.7

196

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.8

307.7

2974

14057

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

307.7

2733

13099

N06AX11

ATC

mirtazapine; oral

3.4

307.7

3836

17147

N05AH04

ATC

quetiapine; oral

4.8

307.7

2380

6484

N05AH03

ATC

olanzapine; systemic

5.5

307.7

785

1553

R52.2

ICD-10 Finland

Other chronic pain

9.6

307.7

969

1133

R52.9

ICD-10 Finland

Pain, unspecified

3.6

307.7

1454

4614

A02BC03

ATC

lansoprazole; oral

2.7

307.7

2869

13815

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.4

307.7

1403

3698

A02BC05

ATC

esomeprazole; systemic

2.8

307.7

4262

22880

M54.5

ICD-10 Finland

Low back pain

2.5

307.7

3894

21951

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

7.9

307.7

720

989

N05BA01

ATC

diazepam; systemic, rectal

4.5

307.7

1609

4275

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

16.7

307.7

472

300

N03AX16

ATC

[U] pregabalin

4.6

307.7

3252

10274

F45.8

ICD-10 Finland

Other somatoform disorders

28.1

307.7

4024

2772

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

8.5

307.7

1199

1625

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.7

307.7

1168

3529

N06AB06

ATC

sertraline; oral

4.2

307.7

1436

3942

R13

ICD-10 Finland

Dysphagia

4.4

307.7

986

2466

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

10.8

307.7

624

619

R52.1

ICD-10 Finland

Chronic intractable pain

16.4

307.7

297

188

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

307.7

2841

13549

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.5

307.7

1560

2880

Z01.8

ICD-10 Finland

Other specified special examinations

2.8

307.7

2575

11629

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

10.2

307.7

874

954

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

254.7

307.7

411

N06AB10

ATC

escitalopram; oral

3.1

307.7

2340

9528

N06AB04

ATC

citalopram; systemic

3.4

307.7

2322

8617

R06.0

ICD-10 Finland

Dyspnoea

2.6

307.7

2712

12958

M79.7

ICD-10 Finland

Fibromyalgia

7.6

307.7

831

1209

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.0

307.7

3104

13917

N03AX12

ATC

[U] gabapentin; oral

5.1

307.7

2591

6821

A02BC02

ATC

pantoprazole; systemic

2.8

307.7

6172

43248

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

182.7

307.7

2215

167

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.8

307.7

1873

4789

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.4

307.7

1266

3263

N06AX16

ATC

venlafaxine; oral

5.4

307.7

2307

5593

F45.0

ICD-10 Finland

Somatization disorder

468.1

307.7

606

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

3.4

307.7

1617

5618

N06AX12

ATC

bupropion; oral

4.3

307.7

969

2474

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

10.6

307.7

441

436

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

19.0

307.7

292

159

N06AA09

ATC

amitriptyline; systemic

5.9

307.7

1596

3255

K07.60

ICD-10 Finland

Snapping jaw

7.2

307.7

1354

2185

F34.1

ICD-10 Finland

Dysthymia

8.1

307.7

577

761

F41.09

ICD-10 Finland

UNS Panic Syndrome

14.2

307.7

449

333

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

10.7

307.7

1047

1110

N03AE01

ATC

clonazepam; systemic

7.6

307.7

1040

1549

F41.00

ICD-10 Finland

Moderate panic disorder

52.5

307.7

274

SBB10

NOMESCO Finland

Dental impressions

4.0

307.7

1047

2867

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.7

306.8

2102

9232

Z2445

NOMESCO Finland

Psychologist

6.3

304.7

534

899

M54.4

ICD-10 Finland

Lumbago with sciatica

2.7

304.1

2136

9494

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.9

302.2

709

1557

F45.2

ICD-10 Finland

Hypochondriacal disorder

78.2

301.5

161

M79.6

ICD-10 Finland

Pain in limb

2.3

297.8

4378

27142

SAA03

NOMESCO Finland

Extended examination of mouth

2.3

294.8

4003

23958

N05AA02

ATC

levomepromazine; systemic

6.7

292.6

480

755

A02BA02

ATC

ranitidine; systemic

2.8

291.5

1866

7891

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.2

289.8

1320

4620

WZC00

NOMESCO Finland

Treatment plan or consultation

2.3

289.1

3684

21411

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

7.1

285.4

443

657

L28

ICPC

Limited function/disability (L)

2.8

282.1

1825

7746

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.3

279.1

4033

24596

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.9

277.3

516

920

M03BX01

ATC

baclofen; systemic

8.1

277.2

382

495

N06AA12

ATC

doxepin; systemic

5.1

276.4

615

1289

M54.2

ICD-10 Finland

Cervicalgia

3.4

276.2

1106

3571

N02BF01

ATC

gabapentin; oral

3.2

275.7

1297

4618

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.2

275.6

794

2046

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.1

272.9

801

2092

SAA04

NOMESCO Finland

Special examination of mouth

4.3

272.7

768

1945

30530

ICD-8 Finland

Physical disorders of presumably psychogenic origin, Cardiovascular

+∞

272.4

260

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.9

268.5

1521

6006

N05AX12

ATC

aripiprazole; systemic

5.9

268.1

496

879

P01

ICPC

Feeling anxious/nervous/tense

2.9

267.6

1486

5804

P74

ICPC

Anxiety disorder/anxiety state

5.2

267.5

577

1177

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.3

264.0

3072

17018

M03BC01

ATC

orphenadrine (citrate); systemic

2.4

263.0

2415

12071

N06AB05

ATC

paroxetine; oral

4.4

261.3

699

1701

UJF32

NOMESCO Finland

Coloscopy

2.4

260.6

2437

12271

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.4

259.6

537

1055

N06AX03

ATC

mianserin; oral

5.2

256.1

555

1136

P76

ICPC

Depressive disorder

3.9

252.2

819

2296

F60.9

ICD-10 Finland

Personality disorder, unspecified

17.0

251.2

209

126

N05CD07

ATC

temazepam; oral

3.4

250.7

1024

3338

M03BX02

ATC

tizanidine; oral

2.3

249.7

5713

41262

ZY010

NOMESCO Finland

Hospital outpatient

4.7

248.7

602

1352

N03AG01

ATC

valproic acid; systemic, rectal

4.3

248.7

682

1690

A06AD11

ATC

lactulose; oral

2.9

246.1

1321

5048

AA1AD

NOMESCO Finland

CT of head and brain

2.3

244.9

2458

12710

SPAT1240

SPAT

Therapeutic discussion

3.1

241.0

1182

4291

M25.5

ICD-10 Finland

Pain in joint

2.2

240.7

3389

20102

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.0

240.0

724

1924

L01

ICPC

Neck symptom/complaint

2.5

238.7

1864

8599

N03AX11

ATC

topiramate; oral

6.1

238.1

429

740

P03

ICPC

Feeling depressed

3.0

237.4

1167

4240

N03AF01

ATC

carbamazepine; oral, rectal

4.5

237.4

614

1453

N06AA10

ATC

nortriptyline; systemic

6.9

236.4

374

565

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

6.1

235.0

423

729

N02AA05

ATC

oxycodone; systemic

2.6

234.7

1619

7032

F40.1

ICD-10 Finland

Social phobias

11.1

234.4

251

233

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.1

234.1

1079

3776

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.5

233.9

1868

8699

P29

ICPC

Psychological sympt/compl other

3.4

231.5

915

2916

N06AX22

ATC

agomelatine; oral

7.3

229.1

345

494

G43.9

ICD-10 Finland

Migraine, unspecified

3.4

227.0

901

2877

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

4.1

225.3

670

1760

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.9

225.2

1181

4442

R03AC02

ATC

salbutamol; inhalant

2.1

225.1

5018

35154

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

7.5

224.5

329

457

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.8

224.3

530

1165

R11

ICD-10 Finland

Nausea and vomiting

3.1

222.6

1019

3546

R51.81

ICD-10 Finland

Facial pain NOS

5.6

222.3

435

811

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

4.9

222.2

515

1114

IGY02

NOMESCO Finland

Psychiatric monitoring contact

6.4

220.3

372

601

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

8.0

219.9

302

389

R07.3

ICD-10 Finland

Other chest pain

3.0

219.8

1132

4212

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

219.3

3974

25677

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.6

218.9

359

563

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.2

218.4

386

653

N05AX08

ATC

risperidone; systemic

3.6

215.7

776

2324

L03

ICPC

Low back symptom/complaint

2.1

214.1

2913

16867

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.0

213.2

1073

3938

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

8.7

213.1

273

323

H02AB06

ATC

prednisolone; systemic

2.1

213.1

4186

27757

C07AB07

ATC

bisoprolol; oral

2.1

212.1

3737

23806

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.6

211.1

747

2212

K30

ICD-10 Finland

Functional dyspepsia

2.7

210.6

1310

5380

IGY99

NOMESCO Finland

Other psychiatric treatment contact

8.5

209.0

273

331

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

8.9

208.8

262

302

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.4

208.7

426

825

N01

ICPC

Headache

2.7

206.0

1337

5605

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

7.7

205.2

292

392

N06AX05

ATC

trazodone; oral

6.5

202.9

341

548

M01AE03

ATC

ketoprofen; systemic, rectal

2.1

202.8

3158

19144

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

201.8

3832

24936

D01

ICPC

Abdominal pain/cramps general

2.6

201.2

1394

6028

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

8.6

200.6

260

312

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

200.6

1624

7553

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

199.8

2139

11213

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.6

198.0

1416

6214

M35.7

ICD-10 Finland

Hypermobility syndrome

7.1

195.5

300

438

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.2

195.1

831

2762

R20.2

ICD-10 Finland

Paraesthesia of skin

3.1

193.4

894

3118

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.0

193.3

937

3358

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

192.2

1395

6157

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

192.1

1012

3797

F45.31

ICD-10 Finland

Somatoform autonomic dysfunction of the upper gastrointestinal tract

66.5

191.7

105

G43.3

ICD-10 Finland

Complicated migraine

6.2

191.4

336

564

N05CF02

ATC

zolpidem; oral

2.4

191.0

1675

8053

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

11.8

189.5

194

168

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.9

189.3

589

1594

K59.09

ICD-10 Finland

Constipation, unspecified

3.4

187.3

725

2270

R06.4

ICD-10 Finland

Hyperventilation

7.4

187.0

274

380

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

186.6

1845

9325

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.5

185.9

1363

6037

UKC02

NOMESCO Finland

Cystoscopy

2.6

185.6

1273

5462

A03FA02

ATC

cisapride; oral, rectal

3.3

182.6

764

2509

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

4.9

181.4

418

898

G47.3

ICD-10 Finland

Sleep apnoea

2.2

181.4

2066

11040

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

180.8

2577

14986

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

179.8

760

2510

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

4.3

179.6

491

1208

K08.80

ICD-10 Finland

Toothache NOS

2.7

178.4

1090

4412

SAA01

NOMESCO Finland

Simple examination of mouth

2.2

178.2

6348

50635

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

2.0

176.8

4900

35684

F45.33

ICD-10 Finland

Somatoform autonomic dysfunction respiratory organs

307.5

176.7

179

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

176.3

4193

29006

M89.0

ICD-10 Finland

Algoneurodystrophy

9.8

175.4

205

215

M54.6

ICD-10 Finland

Pain in thoracic spine

2.9

174.5

914

3411

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

10.1

174.1

198

200

Z2446

NOMESCO Finland

Social worker

3.5

173.9

632

1898

A04

ICPC

Weakness/tiredness general

2.3

173.0

1534

7380

F60.5

ICD-10 Finland

Anankastic personality disorder

10.6

172.8

190

183

L17

ICPC

Foot/toe symptom/complaint

2.0

171.8

2759

16681

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

169.8

2400

13856

F41.01

ICD-10 Finland

Severe panic disorder

54.0

168.8

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.2

168.3

720

2392

K07.61

ICD-10 Finland

Cracking jaw joint

5.1

167.4

363

740

R02

ICPC

Shortness of breath/dyspnoea

2.5

167.2

1278

5750

M01AE02

ATC

naproxen; oral, rectal

1.9

166.7

4970

36748

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.3

165.6

671

2157

M01AH01

ATC

celecoxib; oral

2.2

164.4

1644

8299

A02BC04

ATC

rabeprazole; oral

2.7

164.0

974

3877

N06AG02

ATC

moclobemide; oral

4.3

163.6

436

1051

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

5.4

163.4

329

628

F41.8

ICD-10 Finland

Other specified anxiety disorders

4.8

163.4

376

806

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

8.0

162.3

223

287

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.8

162.2

896

3434

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

161.5

902

3477

F51.0

ICD-10 Finland

Nonorganic insomnia

2.2

161.2

1738

9034

J02AC01

ATC

fluconazole; systemic

1.9

158.8

3762

25687

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.9

158.8

817

3013

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.5

157.8

1131

4930

N05AB03

ATC

perphenazine; systemic, rectal

4.9

156.6

358

763

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

156.0

3778

25928

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.5

155.3

579

1765

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

154.9

1790

9541

F45.30

ICD-10 Finland

Somatoform autonomic dysfunction of the heart and circulation

1567.3

154.6

150

P99

ICPC

Psychological disorders other

4.8

154.4

357

768

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

11.2

154.3

163

148

ZYC01

NOMESCO Finland

Remote contact by phone

3.2

153.0

648

2137

J01FF01

ATC

clindamycin; systemic

2.0

153.0

2375

14080

P01AB01

ATC

metronidazole; oral, rectal

1.9

152.6

3555

24049

L02

ICPC

Back symptom/complaint

2.5

152.5

1138

5049

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

8.5

151.9

198

239

N05AF03

ATC

chlorprothixene; systemic

5.8

150.8

279

492

K59.0

ICD-10 Finland

Constipation

3.3

150.3

590

1857

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

149.5

1061

4597

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

8.4

149.3

195

236

M50.3

ICD-10 Finland

Other cervical disc degeneration

4.9

148.6

339

721

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

11.8

148.0

151

130

N06AA04

ATC

clomipramine; systemic

7.4

147.9

217

301

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

12.9

147.0

142

112

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

42.4

146.8

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

146.7

1738

9329

N05BA06

ATC

lorazepam; systemic, sublingual

3.8

145.7

457

1240

R21

ICPC

Throat symptom/complaint

2.0

145.6

2178

12710

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

7.9

145.5

202

263

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

145.1

2519

15453

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

20.1

144.7

111

M48.0

ICD-10 Finland

Spinal stenosis

2.5

144.1

1031

4479

R01AD09

ATC

mometasone; nasal

1.8

143.2

4099

29338

A03CA02

ATC

clidinium and psycholeptics; oral

3.3

141.7

554

1738

G50.0

ICD-10 Finland

Trigeminal neuralgia

5.5

140.7

276

514

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.7

139.7

336

746

R07.0

ICD-10 Finland

Pain in throat

2.6

138.2

856

3467

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.6

137.6

475

1375

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

136.5

1207

5752

N02BE01

ATC

paracetamol; systemic, rectal

2.6

136.1

7339

64177

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.4

135.6

351

826

R06AE07

ATC

cetirizine; oral

1.8

135.6

3917

27947

SFA10

NOMESCO Finland

One-surface restoration

1.8

134.5

4802

36406

Z02.7

ICD-10 Finland

Issue of medical certificate

2.8

134.4

734

2786

S06.0

ICD-10 Finland

Concussion

2.4

134.3

1013

4501

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

134.2

3538

24553

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.5

134.1

262

486

F41.3

ICD-10 Finland

Other mixed anxiety disorders

7.5

134.1

193

262

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

16.8

133.1

111

N03AF02

ATC

oxcarbazepine; oral

4.1

132.0

375

947

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.5

131.5

471

1396

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.7

131.1

431

1207

F32.8

ICD-10 Finland

Other depressive episodes

6.3

131.0

222

359

30550

ICD-8 Finland

Physical disorders of presumably psychogenic origin, Gastro-intestinal

+∞

130.6

125

TAC99

NOMESCO Finland

Other blockade for chronic pain

10.5

130.0

144

140

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

130.0

1739

9706

M01AH02

ATC

rofecoxib; oral

2.3

129.7

1065

4909

M01AB05

ATC

diclofenac; systemic, rectal

1.8

129.6

5453

43160

R00.2

ICD-10 Finland

Palpitations

2.5

129.3

869

3657

K07.62

ICD-10 Finland

Habitual dislocation of the jaw joint

8.7

128.6

163

190

A11

ICPC

Chest pain NOS

2.6

128.5

802

3256

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

9.4

128.4

154

167

F45.39

ICD-10 Finland

Somatoform autonomic dysfunction multiple or indeterminate organs

431.2

128.3

128

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

128.2

1422

7405

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

24.2

128.1

N06AA06

ATC

trimipramine; systemic

5.2

127.8

268

530

K03.00

ICD-10 Finland

Approximal wear

2.6

127.6

848

3548

A07AA02

ATC

nystatin; oral

3.1

127.5

572

1946

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.0

127.1

377

982

F39

ICD-10 Finland

Unspecified mood [affective] disorder

6.2

125.8

216

354

D20

ICPC

Mouth/tongue/lip symptom/complaint

3.2

125.3

538

1784

G54.0

ICD-10 Finland

Brachial plexus disorders

4.0

125.1

371

966

Z01.2

ICD-10 Finland

Dental examination

1.7

125.0

4170

30734

D06

ICPC

Abdominal pain localized other

2.4

125.0

943

4184

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

26.8

124.2

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

124.0

1274

6433

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

124.0

6048

49691

J01MA02

ATC

ciprofloxacin; systemic

1.8

123.6

3008

20255

R03DC03

ATC

montelukast; oral

2.0

123.3

1599

8807

Z3231

NOMESCO Finland

Registered nurse

1.9

122.9

2103

12719

SPAT1263

SPAT

Sampling

1.7

122.9

3447

24161

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

6.0

122.6

221

380

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.7

122.5

232

418

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

122.4

2437

15449

Z71.8

ICD-10 Finland

Other specified counselling

1.8

122.0

2989

20148

G56.4

ICD-10 Finland

Causalgia

13.4

122.0

115

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

121.3

1189

5890

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

121.0

2208

13618

N17

ICPC

Vertigo/dizziness

2.2

120.7

1128

5481

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

11.3

120.2

126

113

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

120.1

747

3024

Z50.1

ICD-10 Finland

Other physical therapy

3.1

120.0

535

1813

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.9

119.9

363

959

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.8

119.8

382

1047

R01AD08

ATC

fluticasone; nasal

1.8

119.3

2568

16642

SAA02

NOMESCO Finland

Basic examination of mouth

1.8

119.3

5796

47223

UJD02

NOMESCO Finland

Gastroscopy

3.3

119.2

484

1551

C07AB02

ATC

metoprolol; systemic

2.1

119.2

1409

7496

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

119.1

2641

17263

P06

ICPC

Sleep disturbance

2.2

119.0

1223

6170

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

118.9

1159

5725

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

5.2

118.2

246

483

WZA90

NOMESCO Finland

Other medical or dental certificate

1.9

118.2

2070

12588

N06AX17

ATC

milnacipran; oral

7.7

117.8

165

217

R51

ICD-10 Finland

Headache

2.7

117.5

658

2525

M01AH05

ATC

etoricoxib; oral

1.8

117.5

5250

41647

L86

ICPC

Back syndrome with radiating pain

2.8

117.4

647

2462

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.0

117.3

350

915

F48.0

ICD-10 Finland

Neurasthenia

29.9

116.6

K02.1

ICD-10 Finland

Caries of dentine

1.7

116.5

5058

39752

Z3226

NOMESCO Finland

Physiotherapist

2.0

116.4

1463

7952

M54.1

ICD-10 Finland

Radiculopathy

3.3

115.7

458

1445

SPAT1301

SPAT

No procedures

1.8

114.8

2456

15849

S29

ICPC

Skin symptom/complaint other

1.9

114.8

1765

10277

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

114.6

2429

15632

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.0

114.5

551

1949

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.0

114.3

535

1863

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

14.5

114.3

103

L12

ICPC

Hand/finger symptom/complaint

2.0

114.2

1598

9011

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

3.5

114.1

419

1261

S18

ICPC

Laceration/cut

1.7

113.9

3668

26528

R10.2

ICD-10 Finland

Pelvic and perineal pain

4.1

113.8

324

819

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.4

113.6

436

1349

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.8

113.5

598

2222

K59.1

ICD-10 Finland

Functional diarrhoea

2.9

113.4

575

2093

M02AA07

ATC

piroxicam; topical

1.8

113.2

2767

18540

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.7

113.1

670

2644

N06BA04

ATC

methylphenidate; oral

3.7

112.7

366

1015

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

112.7

936

4321

R35

ICD-10 Finland

Polyuria

2.8

112.5

586

2163

M01AB55

ATC

diclofenac, combinations; oral

2.8

112.4

594

2210

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.6

111.9

386

1115

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.9

111.9

341

905

J31.0

ICD-10 Finland

Chronic rhinitis

2.4

111.8

884

3995

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

376.0

111.7

112

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

111.4

964

4527

J01AA02

ATC

doxycycline; systemic

1.9

111.4

6230

52284

N04BC05

ATC

pramipexole; oral

2.6

110.9

675

2700

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.5

110.4

392

1154

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.2

110.2

456

1477

R33

ICD-10 Finland

Retention of urine

2.9

109.9

559

2037

30599

ICD-8 Finland

Physical disorders of presumably psychogenic origin, Other

+∞

109.6

105

N89

ICPC

Migraine

3.2

109.5

462

1514

SFA20

NOMESCO Finland

Two-surface restoration

1.7

109.4

4985

39363

R96

ICPC

Asthma

2.3

108.9

936

4382

E0000UV, ,

ATC

1.7

108.8

3520

25388

H01

ICPC

Ear pain/earache

2.1

108.6

1166

5966

A01AB09

ATC

miconazole; local oral

2.5

108.5

769

3306

N02AC04

ATC

dextropropoxyphene; oral

3.9

108.3

325

853

F32.1

ICD-10 Finland

Moderate depressive episode

2.7

108.3

609

2340

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

108.1

1116

5624

M01AC06

ATC

meloxicam; systemic, rectal

1.7

107.9

2932

20169

SPAT1254

SPAT

Administration of medicine

2.1

107.7

1150

5870

R12

ICD-10 Finland

Heartburn

2.4

107.4

848

3826

XA800

NOMESCO Finland

Neuropsychological investigation

3.3

107.3

423

1330

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

107.2

931

4375

R05

ICPC

Cough

1.8

105.8

2176

13819

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

105.6

2053

12820

A28

ICPC

Limited function/disability NOS

2.1

105.6

1223

6433

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

105.5

1277

6825

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.0

105.4

303

771

WX002

NOMESCO Finland

Sedation and analgesia

1.9

104.3

1497

8488

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

104.1

1755

10485

J01EA01

ATC

trimethoprim; systemic

1.8

104.0

2195

14035

J01FA06

ATC

roxithromycin; oral

1.7

103.9

3185

22565

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

6.9

103.1

161

239

R52.0

ICD-10 Finland

Acute pain

3.4

103.1

393

1210

M01AG02

ATC

tolfenamic acid; oral, rectal

2.0

102.8

1397

7770

M54.8

ICD-10 Finland

Other dorsalgia

2.9

102.7

512

1844

J01DB01

ATC

cefalexin; oral

1.9

102.7

6738

58436

M01AX17

ATC

nimesulide; oral

1.8

102.6

1811

10967

N30.0

ICD-10 Finland

Acute cystitis

1.9

102.3

1583

9195

Z00.0

ICD-10 Finland

General medical examination

1.9

102.2

1599

9320

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

101.9

1466

8311

TAB00

NOMESCO Finland

Lumbar puncture

3.0

101.6

468

1613

C03CA01

ATC

furosemide; systemic

1.8

101.3

1870

11475

H03AA01

ATC

levothyroxine sodium; systemic

1.8

101.2

1979

12355

X58

ICD-10 Finland

Exposure to other specified factors

2.0

101.2

1329

7302

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

29.4

100.8

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

100.6

851

3950

N07BC02

ATC

methadone; systemic

13.8

100.6

U07

ICPC

Urine symptom/complaint other

2.4

100.5

754

3322

F33.8

ICD-10 Finland

Other recurrent depressive disorders

8.3

100.4

132

161

M54.3

ICD-10 Finland

Sciatica

2.6

100.4

605

2405

3007

Kela drug reimbursment

Erenumab and fremanezumab

5.1

100.1

214

430

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

99.6

1600

9397

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

99.2

1123

5848

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

4.7

99.2

235

515

H02AB07

ATC

prednisone; oral

2.1

98.4

1119

5835

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.9

98.1

477

1694

R05

ICD-10 Finland

Cough

1.8

98.0

1860

11493

SXC05

NOMESCO Finland

Other oral or dental procedure

2.5

97.8

691

2962

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

10.1

97.3

110

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

97.3

826

3838

XA402

NOMESCO Finland

ENMG

3.9

97.1

294

776

D02

ICPC

Abdominal pain epigastric

2.5

96.9

648

2707

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.6

96.8

185

336

H02AB04

ATC

methylprednisolone; systemic

2.0

96.7

1218

6586

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

96.4

1094

5698

R50.9

ICD-10 Finland

Fever, unspecified

2.0

95.9

1259

6905

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

3.1

95.9

424

1427

K10.3

ICD-10 Finland

Alveolitis of jaws

2.8

95.6

526

1995

H92.0

ICD-10 Finland

Otalgia

2.4

95.6

685

2954

A29

ICPC

General symptom/complaint other

2.1

95.5

1103

5781

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

13.6

95.4

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

9.6

95.4

112

118

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

10.3

95.1

106

104

J01FA10

ATC

azithromycin; systemic

1.6

95.1

4870

38931

T78.4

ICD-10 Finland

Allergy, unspecified

2.8

95.0

494

1819

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

94.8

2547

17323

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

94.7

2385

15944

L04

ICPC

Chest symptom/complaint

2.5

94.2

629

2625

R55

ICD-10 Finland

Syncope and collapse

2.2

94.2

856

4089

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

14.3

93.7

SPAT1307

SPAT

Psychosocial counselling and guidance

2.6

93.6

559

2210

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

93.2

763

3488

D11

ICPC

Diarrhoea

2.0

93.2

1115

5915

N05AF01

ATC

flupentixol; systemic

6.2

93.1

159

259

A02BA04

ATC

nizatidine; systemic

2.6

93.1

595

2432

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.6

92.7

571

2292

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

92.7

2174

14239

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

16.9

92.7

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.0

92.6

431

1493

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

92.5

1260

6991

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

5.9

92.5

166

284

J01DA01

ATC

[U] cefalexin

1.6

92.4

4896

39328

G50.8

ICD-10 Finland

Other disorders of trigeminal nerve

15.5

92.2

R01AD58

ATC

fluticasone, combinations; nasal

1.7

92.2

2341

15662

U02

ICPC

Urinary frequency/urgency

1.9

92.0

1295

7264

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

6.8

91.8

145

218

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.5

91.7

178

328

F45.3

ICD-10 Finland

Somatoform autonomic dysfunction

237.7

91.7

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

91.7

1136

6099

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.8

91.3

479

1771

ZY000

NOMESCO Finland

Hospital inpatient

7.4

91.3

133

183

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.9

90.6

271

709

A99

ICPC

Disease/condition unspecnature/site

2.2

90.5

896

4424

H57.1

ICD-10 Finland

Ocular pain

2.9

90.4

443

1579

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

90.1

2214

14667

M03AX01

ATC

botulinum toxin; parenteral

4.7

89.9

209

451

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

89.9

1846

11633

TEG00

NOMESCO Finland

Punction of mandibular joint

26.0

89.5

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.8

89.5

475

1767

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.9

89.4

449

1622

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

89.3

792

3742

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

6.0

89.1

157

264

L29

ICPC

Musculoskeletal sympt/complt other

2.2

89.0

812

3880

R03BB04

ATC

tiotropium bromide; inhalant

2.3

89.0

715

3241

C01CA24

ATC

epinephrine; parenteral

2.4

88.9

641

2769

XQ800

NOMESCO Finland

Prick test

2.3

88.8

734

3367

A02BX02

ATC

sucralfate; oral

3.3

88.8

341

1054

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

88.6

3422

25383

C08DA01

ATC

verapamil; systemic

3.2

88.6

366

1183

R60.0

ICD-10 Finland

Localized oedema

2.0

88.5

1022

5346

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

88.5

485

1835

F33

ICD-10 Finland

Recurrent depressive disorder

3.9

88.4

262

681

WX290

NOMESCO Finland

Other blockage of nerve

1.6

88.3

4069

31464

SPAT1310

SPAT

Counselling related to known health issue

1.7

88.2

2443

16682

G44.0

ICD-10 Finland

Cluster headache syndrome

5.8

88.2

163

287

F45.32

ICD-10 Finland

Somatoform autonomic dysfunction of the lower gastrointestinal tract

16.1

88.1

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

25.6

87.6

AA400

NOMESCO Finland

Electroconvulsive therapy

10.5

87.5

D09

ICPC

Nausea

2.7

87.0

478

1810

WYA10

NOMESCO Finland

Emergency care or similar visit

2.3

87.0

701

3180

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

4.0

86.8

256

663

A06AC51

ATC

ispaghula, combinations; oral

2.8

86.7

458

1699

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

86.6

1153

6337

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.3

86.6

338

1055

F45.34

ICD-10 Finland

Somatoform autonomic dysfunction genitourinary organs

30.2

86.5

F60.8

ICD-10 Finland

Other specific personality disorders

11.4

86.3

SPAT1260

SPAT

Consultation of another employee

1.9

86.3

1368

7963

R03BA05

ATC

fluticasone; inhalant

1.8

86.2

1538

9284

L13

ICPC

Hip symptom/complaint

1.8

85.8

1563

9492

SPAT1229

SPAT

Assessment of need for aid

2.5

85.6

574

2397

XKD00

NOMESCO Finland

Uroflowmetry

2.1

85.5

882

4420

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

85.5

367

1213

Z00.8

ICD-10 Finland

Other general examinations

2.3

85.4

721

3335

C05AA08

ATC

fluocortolone; rectal, topical

2.0

85.3

1102

5992

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

84.9

2210

14824

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.2

84.8

816

3980

R4110, ,

SPAT

2.0

84.7

1131

6219

SPAT1216

SPAT

Assessment of functional ability

2.0

84.7

1057

5678

M01AX01

ATC

nabumetone; oral

3.0

84.6

393

1359

K07.68

ICD-10 Finland

Other disorders of the jaw joint

6.3

84.4

143

231

D12

ICPC

Constipation

3.2

84.4

343

1097

G47.8

ICD-10 Finland

Other sleep disorders

3.8

84.3

260

695

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

24.2

84.3

R4110

NOMESCO Finland

Physiotherapy

1.7

84.3

2106

13968

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

10.4

84.2

J01MA12

ATC

levofloxacin; systemic

1.9

84.2

1347

7857

R06.5

ICD-10 Finland

Mouth breathing

2.2

83.7

777

3736

S03.0

ICD-10 Finland

Dislocation of jaw

7.0

83.6

127

183

F60.7

ICD-10 Finland

Dependent personality disorder

20.2

83.6

C10AC01

ATC

colestyramine; oral

3.5

83.5

299

884

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

83.5

910

4655

N06AB08

ATC

fluvoxamine; oral

4.0

83.2

241

616

K07.24

ICD-10 Finland

Open bite

5.2

83.2

174

343

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

83.0

1147

6377

F50.9

ICD-10 Finland

Eating disorder, unspecified

7.0

82.8

126

182

L08

ICPC

Shoulder symptom/complaint

1.7

82.7

1897

12286

F32

ICD-10 Finland

Depressive episode

2.6

82.6

489

1922

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

17.1

82.4

J37.0

ICD-10 Finland

Chronic laryngitis

3.2

82.3

344

1119

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.0

82.1

389

1360

U01

ICPC

Dysuria/painful urination

2.2

81.9

746

3558

IBA03

NOMESCO Finland

Psychotherapy evaluation

9.3

81.9

106

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

9.0

81.3

100

112

G44.8

ICD-10 Finland

Other specified headache syndromes

4.3

81.3

211

497

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.6

81.1

154

278

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

81.1

1483

9001

IHZ05, ,

SPAT

2.8

81.0

434

1621

R03BA02

ATC

budesonide; inhalant

1.8

80.4

1491

9083

U05

ICPC

Urination problems other

2.8

80.4

427

1588

3008A

ICD-9 Finland

Neurotic disorders, Other neurotic disorders

+∞

80.3

Z08

ICPC

Social welfare problem

5.7

80.0

151

271

A97

ICPC

No disease

1.8

79.9

1618

10110

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

79.8

4461

35704

R30.0

ICD-10 Finland

Dysuria

2.7

79.5

441

1677

A01AB04

ATC

amphotericin B; local oral

2.9

79.3

387

1375

G43.8

ICD-10 Finland

Other migraine

4.2

79.3

217

532

F43.29

ICD-10 Finland

Adaptation disorder UNS

4.3

78.2

203

478

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

7.8

78.1

108

140

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.0

78.0

1027

5610

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

77.7

568

2466

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

5.6

77.6

147

265

M02AA10

ATC

ketoprofen; topical

1.8

77.2

1267

7430

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

3.0

77.2

365

1274

A05

ICPC

Feeling ill

2.4

76.8

577

2535

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.4

76.5

127

201

R06AX27

ATC

desloratadine; oral

1.6

76.4

2542

18029

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

76.3

4261

33949

R4140

NOMESCO Finland

Psychotherapy

11.0

76.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

76.2

378

1355

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

76.1

988

5369

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

7.1

76.0

115

165

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

75.8

2604

18599

EGA00

NOMESCO Finland

Arthroscopy of mandibular joint

14.2

75.8

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

75.7

1019

5604

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

6.9

75.6

117

172

L15

ICPC

Knee symptom/complaint

1.7

75.5

2032

13674

M54

ICD-10 Finland

Dorsalgia

1.9

75.4

1135

6474

EBA00

NOMESCO Finland

Extraction of tooth

1.6

75.4

2883

21105

R4120

NOMESCO Finland

Occupational therapy

2.4

75.1

568

2502

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

75.1

1826

11968

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

75.0

637

2949

K07.4

ICD-10 Finland

Malocclusion, unspecified

4.0

74.8

216

551

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

74.8

933

4999

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

74.7

412

1562

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.8

74.5

394

1461

IGY02, ,

SPAT

4.9

74.5

164

338

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.7

74.5

412

1564

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.3

74.3

626

2888

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.3

74.1

285

881

P80

ICPC

Personality disorder

13.3

74.1

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

4.6

73.9

178

395

-1, ,

NOMESCO Finland

1.6

73.8

2702

19558

N05AN01

ATC

lithium; oral

4.2

73.8

196

470

D07AC01

ATC

betamethasone; topical

1.6

73.1

2841

20835

30520

ICD-8 Finland

Physical disorders of presumably psychogenic origin, Respiratory

+∞

73.0

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.7

72.6

406

1550

R03AC03

ATC

terbutaline; inhalant

1.8

72.4

1150

6667

G04CA02

ATC

tamsulosin; oral

1.8

72.2

1147

6650

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

16.8

72.0

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

72.0

JAH01

NOMESCO Finland

Laparoscopy

2.6

71.8

452

1829

R25.2

ICD-10 Finland

Cramp and spasm

3.4

71.7

262

784

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

5.5

71.7

139

256

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.7

71.6

169

369

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

71.6

641

3031

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.8

71.5

223

601

R68.2

ICD-10 Finland

Dry mouth, unspecified

6.8

71.4

111

164

S21

ICPC

Skin texture symptom/complaint

1.8

71.4

1208

7138

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

71.3

1196

7048

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

19.8

71.2

SFA30

NOMESCO Finland

Three-surface restoration

1.5

71.1

3328

25381

K03.80

ICD-10 Finland

Irradiated enamel

2.3

71.0

572

2588

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

71.0

1323

8043

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

70.9

632

2983

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

70.6

355

1281

XF402

NOMESCO Finland

ECG with work load test

2.1

70.6

728

3637

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

70.5

806

4183

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

10.8

70.5

WZC00, ,

SPAT

1.8

70.2

1256

7543

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

70.1

600

2784

KMAK, ,

NOMESCO Finland

1.5

69.9

4141

33154

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.9

69.8

1068

6115

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.7

69.6

1608

10368

Z01.7

ICD-10 Finland

Laboratory examination

1.7

69.6

1379

8528

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

69.5

2346

16617

F22.0

ICD-10 Finland

Delusional disorder

5.2

69.4

144

282

Z2221

NOMESCO Finland

Medical doctor

1.6

69.3

2067

14217

N05BA02

ATC

chlordiazepoxide; systemic

4.2

69.3

188

458

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

4.1

69.1

192

476

F43.00

ICD-10 Finland

Acute stress reaction mild

3.7

68.9

224

621

F40.2

ICD-10 Finland

Specific (isolated) phobias

10.8

68.7

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

68.7

617

2920

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.9

68.6

941

5198

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.3

68.6

177

415

N02CC07

ATC

frovatriptan; oral

2.5

68.6

453

1875

C09CA06

ATC

candesartan; oral

1.6

68.3

1898

12825

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

67.8

766

3955

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.5

67.7

455

1898

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

8.1

67.7

114

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

6.0

67.7

120

203

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

67.5

832

4431

L18

ICPC

Muscle pain

2.6

67.5

413

1648

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

15.8

67.4

N02CD01

ATC

erenumab; parenteral

5.2

67.4

138

267

EB1MA

NOMESCO Finland

Cephalometry with X-ray

3.4

67.2

242

718

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.3

67.1

564

2596

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

67.0

1710

11300

SPAT1153

SPAT

Removal of sutures

1.6

67.0

2219

15623

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

5.2

66.8

138

269

K07.58

ICD-10 Finland

Other abnormal function of teeth and jaws

5.4

66.7

131

244

R03BA01

ATC

beclometasone; inhalant

1.8

66.7

1110

6514

SPAT1097

SPAT

Recording of ECG

1.9

66.7

988

5592

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.8

66.7

207

556

H02AB09

ATC

hydrocortisone; systemic

3.4

66.5

244

732

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.2

66.4

573

2666

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

66.4

1727

11464

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.2

66.4

581

2719

G93.3

ICD-10 Finland

Postviral fatigue syndrome

8.0

66.3

114

N02CC06

ATC

eletriptan; oral

2.6

66.2

389

1521

J45

ICD-10 Finland

Asthma

1.9

66.2

906

4997

IEY01

NOMESCO Finland

Psychoeducation, individual

8.7

66.2

XKC03

NOMESCO Finland

Water cystometry

3.2

66.0

271

872

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.7

65.6

152

327

D19

ICPC

Teeth/gum symptom/complaint

1.5

65.6

2595

18995

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

65.4

2991

22580

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

65.3

2438

17616

SGA01

NOMESCO Finland

Emergency treatment

1.7

65.2

1398

8819

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

65.0

2341

16774

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

65.0

586

2775

N02CC05

ATC

almotriptan; oral

2.5

64.9

413

1679

EB1VA, ,

NOMESCO Finland

1.7

64.9

1524

9850

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

64.8

472

2043

F29

ICPC

Eye symptom/complaint other

1.9

64.7

905

5025

N76.0

ICD-10 Finland

Acute vaginitis

2.1

64.7

657

3260

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.4

64.6

240

726

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

64.5

584

2770

N02CC03

ATC

zolmitriptan; nasal, oral

2.3

64.5

536

2455

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandibular joint with high intensity magnet

20.5

64.5

R03BA08

ATC

ciclesonide; inhalant

2.0

64.4

759

3977

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.2

64.2

172

415

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

9.5

64.2

R39.1

ICD-10 Finland

Other difficulties with micturition

3.2

64.1

256

810

K07.6

ICD-10 Finland

Temporomandibular joint disorders

5.4

64.0

127

239

F93.89

ICD-10 Finland

Other childhood emotional disorders

9.9

63.9

K29.7

ICD-10 Finland

Gastritis, unspecified

2.9

63.7

313

1115

J01FA09

ATC

clarithromycin; systemic

1.5

63.7

2490

18152

R1250

NOMESCO Finland

Evaluation of functional capability

3.4

63.7

233

698

G04BD04

ATC

oxybutynin; oral, transdermal

2.5

63.7

401

1622

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.5

63.6

435

1829

SPAT1284

SPAT

Extensive health certificate

3.2

63.3

253

801

SPAT1312

SPAT

General health counselling

1.5

63.1

2403

17409

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

63.0

688

3506

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

13.9

63.0

K80

ICPC

Cardiac arrhythmia NOS

2.1

62.7

677

3435

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.9

62.6

878

4877

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

62.6

322

1176

A02BA03

ATC

famotidine; systemic

3.0

62.6

291

1006

K58

ICD-10 Finland

Irritable bowel syndrome

2.9

62.5

297

1039

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

62.4

859

4742

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

62.0

875

4870

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

61.8

333

1246

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

9.1

61.6

K04.1

ICD-10 Finland

Necrosis of pulp

1.9

61.5

930

5290

G43

ICD-10 Finland

Migraine

2.2

61.4

568

2716

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.8

61.4

327

1216

N05AD01

ATC

haloperidol; systemic

3.4

61.4

223

665

R09

ICPC

Sinus symptom/complaint

1.9

61.4

788

4250

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.4

61.3

425

1798

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

61.3

614

3029

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

14.1

61.3

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

61.1

2320

16776

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

61.1

1541

10126

N05AL01

ATC

sulpiride; systemic

4.9

60.7

133

273

N06AX18

ATC

reboxetine; oral

5.5

60.7

118

218

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.2

60.4

164

400

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

60.3

924

5277

L05

ICPC

Flank/axilla symptom/complaint

2.2

60.3

535

2516

K04.08

ICD-10 Finland

Other specified pulpit

2.0

60.3

710

3716

R29

ICPC

Respiratory symptom/complaint other

2.1

60.1

578

2806

SPAT1234

SPAT

Support of social functional capacity

2.7

60.0

343

1323

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

9.1

59.8

R10.0

ICD-10 Finland

Acute abdomen

2.8

59.7

305

1110

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

14.3

59.6

R49.01

ICD-10 Finland

Functional dysphonia

2.8

59.5

298

1073

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.5

59.5

391

1614

R01AD12

ATC

fluticasone furoate; nasal

1.5

59.4

2676

20033

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

59.4

921

5278

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

3.1

59.2

257

854

P01BA02

ATC

hydroxychloroquine; oral

2.0

59.0

709

3735

G04BD12

ATC

mirabegron; oral

1.9

59.0

826

4582

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

58.9

509

2367

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.5

58.9

209

614

K07.13

ICD-10 Finland

Retrognaty, mandibular

4.0

58.8

167

421

R74

ICPC

Upper respiratory infection acute

1.5

58.8

2853

21677

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.3

58.7

155

370

K04.09

ICD-10 Finland

Pulpit UNS

2.4

58.6

433

1884

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

58.6

654

3357

SPAT1243

SPAT

Psychiatric/psychological examination

3.2

58.5

238

761

SCA01

NOMESCO Finland

Preventive oral health care, short

1.5

58.5

2351

17175

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.0

58.5

685

3577

M53.2

ICD-10 Finland

Spinal instabilities

5.8

58.2

106

184

KCV04

NOMESCO Finland

Distension of bladder with fluid

5.6

58.2

110

198

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.5

58.2

4205

34496

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

5.9

58.1

105

181

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.6

58.0

195

553

F01

ICPC

Eye pain

2.8

58.0

293

1060

SFA00

NOMESCO Finland

Small restoration

1.7

57.9

1150

7082

N03A

ATC

ANTIEPILEPTICS

15.1

57.9

Z71.9

ICD-10 Finland

Counselling, unspecified

2.0

57.9

677

3532

UJH02

NOMESCO Finland

Anoscopy

2.6

57.9

347

1370

N06BA12

ATC

lisdexamfetamine; oral

5.1

57.7

122

243

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

5.2

57.7

119

232

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

4.3

57.6

148

346

R07.2

ICD-10 Finland

Precordial pain

3.6

57.6

194

551

L16

ICPC

Ankle symptom/complaint

1.8

57.5

1011

6013

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

4.0

57.5

167

428

WX308

NOMESCO Finland

Sacral anesthesy

10.1

57.5

H29

ICPC

Ear symptom/complaint other

1.8

57.4

938

5458

N41.1

ICD-10 Finland

Chronic prostatitis

3.7

57.4

185

510

IHZ04, ,

SPAT

3.9

57.3

172

451

J01CA04

ATC

amoxicillin; systemic

1.6

57.2

6561

58995

N02CC04

ATC

rizatriptan; oral

2.1

57.1

550

2670

ICB06, ,

NOMESCO Finland

9.4

57.1

N02CD03

ATC

fremanezumab; systemic

4.6

57.0

134

292

L29.9

ICD-10 Finland

Pruritus, unspecified

2.9

56.9

270

944

K04

ICPC

Palpitations/awareness of heart

2.3

56.6

454

2047

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.3

56.5

471

2158

J46

ICD-10 Finland

Status asthmaticus

3.0

56.5

263

910

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.9

56.4

265

921

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

56.3

615

3130

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.3

56.3

215

662

K04.0

ICD-10 Finland

Pulpitis

1.9

56.1

797

4440

R25.1

ICD-10 Finland

Tremor, unspecified

3.0

56.0

253

860

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

56.0

820

4612

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

55.7

1060

6447

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.2

55.7

476

2204

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

6.8

55.4

127

E66.8

ICD-10 Finland

Other obesity

2.2

55.4

513

2453

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

55.3

1522

10187

SPAT1058

SPAT

PEF monitoring instruction

2.0

55.3

604

3074

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.1

55.3

563

2792

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.9

55.3

268

948

M01AB01

ATC

indometacin; systemic, rectal

2.3

55.3

462

2119

ZXA00

NOMESCO Finland

Right side

1.6

55.2

1739

12013

H93.1

ICD-10 Finland

Tinnitus

2.1

55.2

587

2958

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.1

55.2

242

809

ZXE00

NOMESCO Finland

One hour or less

1.5

55.1

2834

21704

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.2

54.9

112

216

R06AX13

ATC

loratadine; oral

1.7

54.9

1250

7977

S04

ICPC

Lump/swelling localized

1.8

54.9

892

5179

W0A10

NOMESCO Finland

Mapping of psychosocial situation

10.8

54.8

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

54.8

2671

20240

30041

ICD-8 Finland

Neuroses, Depressiva

5.6

54.6

103

185

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

54.5

2332

17205

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.4

54.4

385

1643

ZXD05

NOMESCO Finland

Urgent procedure

1.5

54.4

2184

15904

E000001, ,

ATC

1.6

54.3

1525

10251

A03

ICPC

Fever

1.6

54.3

1441

9556

M75.8

ICD-10 Finland

Other shoulder lesions

2.4

54.3

373

1571

J01CA08

ATC

pivmecillinam; oral

1.4

54.2

3365

26693

W19

ICD-10 Finland

Unspecified fall

1.9

54.0

728

3985

XF404

NOMESCO Finland

Ambulatory ECG

2.0

53.8

595

3041

N94.1

ICD-10 Finland

Dyspareunia

3.9

53.7

161

422

D03

ICPC

Heartburn

2.5

53.7

343

1396

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

7.0

53.7

119

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.0

53.6

115

232

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

4.8

53.6

121

255

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.8

53.5

280

1032

SXC03

NOMESCO Finland

Other oral or dental procedure

4.7

53.3

123

264

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.2

53.3

453

2092

S02

ICPC

Pruritus

2.6

53.0

314

1232

D07AD01

ATC

clobetasol; topical

1.6

53.0

1306

8500

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

10.2

52.8

K07.23

ICD-10 Finland

Deep bite

3.2

52.6

215

690

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.9

52.6

252

886

R5599

NOMESCO Finland

Other rehabilitation service

3.0

52.4

238

812

R63.4

ICD-10 Finland

Abnormal weight loss

2.6

52.1

310

1219

H53.2

ICD-10 Finland

Diplopia

2.8

52.0

270

991

F45

ICD-10 Finland

Somatoform disorders

14.9

51.9

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.7

51.6

163

443

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.1

51.6

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.8

51.3

939

5639

N02AA03

ATC

hydromorphone; systemic, rectal

12.6

51.2

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

4.2

51.2

138

335

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

4.6

51.1

123

273

C01DA14

ATC

isosorbide mononitrate; oral

1.8

51.1

784

4467

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

51.0

791

4522

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

14.5

51.0

N80.9

ICD-10 Finland

Endometriosis, unspecified

3.2

51.0

210

677

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

9.7

50.9

G24.9

ICD-10 Finland

Dystonia, unspecified

9.7

50.9

R06.2

ICD-10 Finland

Wheezing

2.4

50.7

373

1619

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.9

50.7

245

865

IGV01

NOMESCO Finland

Psychiatric network contact

6.1

50.7

146

G04BD08

ATC

solifenacin; oral

2.2

50.6

448

2102

P18

ICPC

Medication abuse

7.9

50.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

50.4

1010

6218

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

50.3

2859

22215

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

4.5

50.2

122

273

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

50.2

2824

21899

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.6

50.2

166

466

F44.4

ICD-10 Finland

Dissociative motor disorders

+∞

50.0

N03

ICPC

Pain face

4.7

50.0

116

250

A08

ICPC

Swelling

2.2

50.0

427

1975

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.1

50.0

138

341

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

6.1

49.9

145

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

2.0

49.8

535

2703

P25

ICPC

Phase of life problem adult

2.3

49.7

392

1754

L20

ICPC

Joint symptom/complaint NOS

2.4

49.6

351

1498

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

49.3

1135

7247

R06AX22

ATC

ebastine; oral

1.6

49.3

1394

9363

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

49.1

1558

10743

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.0

49.1

140

354

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

+∞

49.0

EBB10

NOMESCO Finland

Insertion of dental implant

3.7

48.9

156

427

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.5

48.7

326

1356

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.0

48.6

222

760

EB1AA, ,

SPAT

2.0

48.6

536

2735

J01MA06

ATC

norfloxacin; oral

1.7

48.5

956

5855

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.8

48.5

109

229

T91.8

ICD-10 Finland

Sequelae of other specified injuries of neck and trunk

13.7

48.5

EDC10

NOMESCO Finland

Sagittal osteotomy of ramus of mandible

4.9

48.3

106

218

A27

ICPC

Fear of other disease NOS

2.3

48.2

396

1802

K11.70

ICD-10 Finland

Hypoptyalism

6.4

48.1

127

G04BD07

ATC

tolterodine; oral

2.4

47.8

329

1386

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

47.8

500

2502

N05AE04

ATC

ziprasidone; systemic

8.5

47.6

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

47.5

484

2398

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.8

47.4

243

886

J20

ICD-10 Finland

Acute bronchitis

1.8

47.3

825

4880

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.6

47.2

274

1065

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

17.0

47.1

SPAT1241

SPAT

Extensive assessment of psychosocial situation

4.6

47.0

113

251

R03AC12

ATC

salmeterol; inhalant

2.4

46.9

326

1379

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

46.9

1457

9989

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

46.9

644

3541

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

46.7

765

4441

A06AX04

ATC

linaclotide; oral

7.9

46.7

M01AC01

ATC

piroxicam; systemic, rectal

1.7

46.6

884

5354

UDC00

NOMESCO Finland

Ear microscopy

2.0

46.6

564

2972

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.8

46.6

106

225

L09

ICPC

Arm symptom/complaint

2.1

46.5

436

2093

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.1

46.4

200

662

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

11.8

46.3

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

46.2

946

5852

C08CA05

ATC

nifedipine; systemic

2.2

46.1

406

1900

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

16.3

46.1

N29

ICPC

Neurological sympt/complt other

3.4

46.0

168

503

F61

ICD-10 Finland

Mixed and other personality disorders

10.9

45.9

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.8

45.9

774

4532

N07BB01

ATC

disulfiram; oral

2.6

45.9

264

1021

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

45.9

1841

13324

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

45.7

724

4162

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.6

45.6

264

1024

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.9

45.6

137

360

WX402

NOMESCO Finland

General anaesthesia

1.5

45.4

1709

12201

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.8

45.4

232

844

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.8

45.4

240

889

R32

ICD-10 Finland

Unspecified urinary incontinence

2.9

45.4

222

789

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

8.9

45.4

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.6

45.4

268

1050

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.1

45.3

478

2399

J34.2

ICD-10 Finland

Deviated nasal septum

2.2

45.2

406

1915

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.6

45.2

1335

9039

K14.60

ICD-10 Finland

Glossopyrosis

5.8

45.2

142

DFF00

NOMESCO Finland

Pure tone audiometry

1.8

45.2

719

4137

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

45.2

2554

19727

J05AB01

ATC

aciclovir; systemic

1.5

45.2

1662

11808

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.0

45.1

129

327

N05AE05

ATC

lurasidone; oral

11.0

45.0

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

45.0

742

4315

F43.8

ICD-10 Finland

Other reactions to severe stress

2.6

45.0

259

1002

F50.1

ICD-10 Finland

Atypical anorexia nervosa

7.6

44.9

30510

ICD-8 Finland

Physical disorders of presumably psychogenic origin, Musculoskeletal

+∞

44.8

N02AJ13

ATC

tramadol and paracetamol; systemic

2.9

44.7

207

714

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

44.6

5266

46098

K03.28

ICD-10 Finland

Other erosion of teeth

2.7

44.5

247

938

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.7

44.5

907

5601

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.2

44.4

177

560

C08CA01

ATC

amlodipine; oral

1.4

44.3

2383

18225

T74.1

ICD-10 Finland

Physical abuse

3.4

44.3

158

466

SPC10

NOMESCO Finland

Standard dental crown

3.5

44.3

154

447

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

44.3

1654

11784

J45.8

ICD-10 Finland

Mixed asthma

2.6

44.2

252

970

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

44.2

923

5736

A03DA02

ATC

pitofenone and analgesics; systemic

3.5

44.2

153

443

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

3.1

44.1

184

598

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

5.2

44.1

174

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

44.1

377

1744

B01AB05

ATC

enoxaparin; parenteral

1.5

44.0

2146

16115

G83.4

ICD-10 Finland

Cauda equina syndrome

7.1

44.0

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

43.9

535

2824

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

43.8

447

2215

S01

ICPC

Pain/tenderness of skin

2.2

43.8

368

1690

N05CD02

ATC

nitrazepam; oral

4.2

43.8

116

278

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

43.7

461

2312

F40.8

ICD-10 Finland

Other phobic anxiety disorders

9.9

43.6

TAC00

NOMESCO Finland

Peripheral nerve block

7.4

43.6

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

12.3

43.5

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.0

43.5

487

2496

J01MA14

ATC

moxifloxacin; systemic

1.9

43.4

631

3530

L84

ICPC

Back syndrome without radiat pain

2.2

43.4

396

1880

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.5

43.2

269

1082

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.4

43.2

158

474

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

43.1

321

1400

Z72.2

ICD-10 Finland

Drug use

8.2

43.1

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.7

43.1

782

4673

K02.0

ICD-10 Finland

Caries limited to enamel

1.5

43.0

1663

11921

L14

ICPC

Leg/thigh symptom/complaint

1.9

42.9

611

3396

SPAT1211

SPAT

Application of soft bandage

1.9

42.9

606

3360

ICB01, ,

SPAT

4.9

42.8

190

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

16.4

42.7

R15

ICD-10 Finland

Faecal incontinence

2.7

42.7

230

861

J01DA09

ATC

[U] cefadroxil

1.5

42.6

1973

14656

IGP01

NOMESCO Finland

Psychiatric family contact

6.4

42.5

110

L07

ICPC

Jaw symptom/complaint

3.3

42.4

159

484

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.1

42.4

176

570

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

8.4

42.4

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

9.5

42.4

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

6.0

42.3

127

R04

ICPC

Breathing problem other

2.3

42.3

316

1381

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.5

42.3

265

1069

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

42.2

557

3019

79199

ICD-8 Finland

Headache

4.1

42.2

116

286

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

42.1

397

1908

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.0

42.1

516

2729

IAB01, ,

SPAT

6.4

42.1

108

X15

ICPC

Vaginal symptom/complaint other

2.2

42.1

369

1724

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.5

41.9

277

1146

R04.2

ICD-10 Finland

Haemoptysis

2.7

41.7

234

894

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

41.7

1427

9966

P28

ICPC

Limited function/disability (P)

5.3

41.7

157

M01AB51

ATC

indometacin, combinations; oral, rectal

3.1

41.6

173

561

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

41.6

938

5941

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

41.6

1061

6930

F50.0

ICD-10 Finland

Anorexia nervosa

5.9

41.5

126

R01AD01

ATC

beclometasone; nasal

1.6

41.5

1145

7620

N05AB01

ATC

dixyrazine; systemic

5.2

41.5

165

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.7

41.4

845

5212

N05AB04

ATC

prochlorperazine; systemic, rectal

3.1

41.4

176

578

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

41.4

615

3462

ZXA10

NOMESCO Finland

Bilateral

1.6

41.3

1208

8146

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

41.3

1605

11506

R01AD05

ATC

budesonide; nasal

1.9

41.2

580

3210

S80.0

ICD-10 Finland

Contusion of knee

1.8

41.2

630

3578

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

41.2

424

2107

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

41.2

1659

11979

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

8.5

41.2

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.0

41.1

187

639

R75

ICPC

Sinusitis acute/chronic

2.1

41.1

424

2110

WX892

NOMESCO Finland

Monitored bed care

2.0

41.0

484

2527

D07AA02

ATC

hydrocortisone; topical

1.6

40.9

1050

6866

K92.1

ICD-10 Finland

Melaena

2.2

40.9

339

1548

J35.0

ICD-10 Finland

Chronic tonsillitis

2.0

40.9

468

2417

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.9

40.8

578

3205

N07CA01

ATC

betahistine; oral

2.0

40.8

493

2595

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.8

40.7

208

757

SDA03

NOMESCO Finland

Periodontal treatment

1.4

40.7

3242

26430

P20

ICPC

Memory disturbance

1.7

40.7

762

4592

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

9.5

40.6

SBA00

NOMESCO Finland

Microbiological examinations

2.7

40.5

215

798

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

40.5

491

2587

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.7

40.5

130

358

L04AX03

ATC

methotrexate; systemic

1.7

40.4

758

4568

A04AA01

ATC

ondansetron; systemic, rectal

1.8

40.4

616

3495

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

6.5

40.3

100

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

4.0

40.3

114

287

R49.08

ICD-10 Finland

Other specified dysphonia

2.8

40.3

204

739

R06AE09

ATC

levocetirizine; oral

1.6

40.3

1147

7684

R03AC13

ATC

formoterol; inhalant

2.2

40.3

370

1761

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

2.4

40.2

274

1149

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

40.2

376

1802

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.1

40.2

169

552

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

2.3

40.2

301

1317

SPAT1167

SPAT

Insertion of urinary catheter

3.0

40.1

183

626

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

40.0

847

5276

D10

ICPC

Vomiting

1.9

39.9

495

2627

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

10.8

39.9

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

7.8

39.9

X78

ICD-10 Finland

Intentional self-harm by sharp object

7.6

39.8

E87.6

ICD-10 Finland

Hypokalaemia

2.5

39.8

250

1009

IBA01, ,

SPAT

3.0

39.8

181

618

D21

ICPC

Swallowing problem

3.7

39.8

127

348

L99

ICPC

Musculoskeletal disease other

2.8

39.8

203

738

IER01

NOMESCO Finland

Psychoeducation, group

6.7

39.8

S22.3

ICD-10 Finland

Fracture of rib

1.9

39.8

496

2637

SPAT1360

SPAT

Extensive global examination

2.0

39.7

468

2441

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

9.4

39.7

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

39.7

835

5191

U71

ICPC

Cystitis/urinary infection other

1.9

39.6

558

3089

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

8.7

39.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

39.5

1217

8294

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

39.5

627

3601

XCK00

NOMESCO Finland

Perimetry

2.0

39.5

418

2099

R5110, ,

SPAT

1.8

39.5

584

3283

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

39.4

776

4739

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

39.4

388

1897

R01AD11

ATC

triamcinolone; nasal

1.8

39.3

655

3815

R30.1

ICD-10 Finland

Vesical tenesmus

2.9

39.3

182

628

F60.0

ICD-10 Finland

Paranoid personality disorder

10.5

39.3

N05AX15

ATC

cariprazine; oral

8.8

39.2

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.0

39.2

179

613

RS221, ,

NOMESCO Finland

3.9

39.1

115

298

L19

ICPC

Muscle symptom/complaint NOS

2.5

39.0

253

1037

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

39.0

586

3310

D93

ICPC

Irritable bowel syndrome

3.4

38.9

143

430

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.1

38.9

160

516

SPAT1255

SPAT

Intravenous administration of medicine

2.0

38.9

451

2340

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

3.0

38.8

171

574

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

38.8

249

1016

N02CD02

ATC

galcanezumab; parenteral

5.7

38.7

128

ZXA05

NOMESCO Finland

Left side

1.5

38.6

1537

11053

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.5

38.6

257

1067

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.2

38.5

347

1639

M77.4

ICD-10 Finland

Metatarsalgia

1.9

38.3

521

2851

R08

ICPC

Nose symptom/complaint other

2.3

38.1

299

1334

M43.1

ICD-10 Finland

Spondylolisthesis

2.2

38.1

318

1456

Z11

ICPC

Compliance/being ill problem

5.3

38.1

144

IHZ05

NOMESCO Finland

Therapeutic conversation

6.9

38.1

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

38.0

619

3581

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

5.4

37.9

141

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.6

37.9

194

Z29

ICPC

Social problem NOS

3.0

37.9

172

587

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

37.7

826

5186

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.8

37.7

192

698

N06AA22, ,

ATC

5.9

37.6

114

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.7

37.6

201

749

F84.5

ICD-10 Finland

Asperger syndrome

6.3

37.6

101

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

37.5

908

5845

30598

ICD-8 Finland

Physical disorders of presumably psychogenic origin, Organorum aliorum definitorum

+∞

37.5

J01MA01

ATC

ofloxacin; systemic

1.9

37.5

529

2928

ZXY60

NOMESCO Finland

2-person team, nurses

7.9

37.4

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

37.4

822

5165

G04CA01

ATC

alfuzosin; oral

1.8

37.4

575

3270

K11.2

ICD-10 Finland

Sialoadenitis

2.3

37.4

286

1263

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

13.5

37.3

RS210, ,

NOMESCO Finland

10.9

37.3

K08.3

ICD-10 Finland

Retained dental root

1.9

37.2

521

2878

SJD00

NOMESCO Finland

Removal and/or reactivation of orthodontic arch wire

2.9

37.2

180

637

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.3

37.1

289

1285

A13

ICPC

Concern/fear medical treatment

3.0

37.1

163

546

IGY99, ,

SPAT

2.9

37.1

174

605

B02AA02

ATC

tranexamic acid; systemic

1.5

36.9

1175

8056

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.7

36.9

196

728

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.8

36.9

550

3098

Z50.4

ICD-10 Finland

Psychotherapy, not elsewhere classified

9.0

36.8

P75

ICPC

Somatization disorder

82.5

36.8

U13

ICPC

Bladder symptom/complaint other

2.6

36.7

223

886

RF120, ,

NOMESCO Finland

4.0

36.7

106

271

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

36.6

350

1691

F34.0

ICD-10 Finland

Cyclothymia

7.9

36.6

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.6

36.5

208

801

30088

ICD-8 Finland

Neuroses, Other

+∞

36.5

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

36.5

2622

20918

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.2

36.3

230

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.3

36.3

294

1330

J01DA06

ATC

[U] cefuroxime

1.6

36.3

1030

6884

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.0

36.1

432

2264

ZX114

NOMESCO Finland

Intramuscular

3.4

36.0

128

377

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

36.0

929

6071

XG466

NOMESCO Finland

Sleep oxymetry

2.6

36.0

207

801

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

10.3

36.0

L11

ICPC

Wrist symptom/complaint

1.7

36.0

758

4709

A01AB10

ATC

natamycin; local oral

2.5

36.0

237

979

D82

ICPC

Teeth/gum disease

1.4

35.9

2945

23971

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.1

35.9

350

1704

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

35.7

447

2379

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

6.1

35.7

103

SPAT1252

SPAT

Overall medication plan or its review

2.0

35.6

396

2023

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

9.2

35.6

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

4.0

35.6

101

255

F41

ICD-10 Finland

Other anxiety disorders

3.0

35.5

161

549

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.8

35.5

109

291

R06AX26

ATC

fexofenadine; oral

1.8

35.5

562

3222

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

35.4

452

2421

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

35.4

276

1228

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

35.4

494

2725

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

52.8

35.4

U04

ICPC

Incontinence urine

2.0

35.4

381

1925

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

4.2

35.2

227

IAA01, ,

SPAT

4.7

35.2

170

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

35.1

559

3210

ZYY01

NOMESCO Finland

Contact between professionals

6.9

35.1

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

35.1

233

966

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.9

35.1

473

2580

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

35.0

633

3772

SPAT1283

SPAT

Restricted health certificate

1.5

35.0

1400

10055

N05BB01

ATC

hydroxyzine; systemic

1.9

35.0

452

2431

J02AC02

ATC

itraconazole; systemic

1.5

34.9

1287

9092

PA6AD

NOMESCO Finland

CT of neck arteries

2.3

34.9

273

1217

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.5

34.9

214

855

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

7.6

34.8

P27

ICPC

Fear of mental disorder

3.7

34.8

108

291

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.9

34.7

106

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.4

34.6

125

372

K59.01

ICD-10 Finland

Constipation outlet obstruction type

3.5

34.6

117

334

SPAT1325

SPAT

Vaccination

1.4

34.6

2130

16538

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.8

34.5

170

607

Z73.9

ICD-10 Finland

Problem related to life-management difficulty, unspecified

4.4

34.5

193

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.1

34.4

319

1523

N05AD03

ATC

melperone; systemic

4.6

34.4

181

F28

ICD-10 Finland

Other nonorganic psychotic disorders

9.4

34.4

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.7

34.4

722

4478

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.6

34.4

841

5422

F31

ICD-10 Finland

Bipolar affective disorder

4.1

34.3

227

XQ802

NOMESCO Finland

Epicutan test

2.1

34.3

351

1740

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

34.3

1522

11147

R20.1

ICD-10 Finland

Hypoaesthesia of skin

4.7

34.2

166

UJC02

NOMESCO Finland

Rigid oesophagoscopy

4.7

34.2

170

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

34.2

385

1976

J39.2

ICD-10 Finland

Other diseases of pharynx

3.8

34.1

103

272

R1250, ,

SPAT

2.4

34.1

245

1053

D29

ICPC

Digestive symptom/complaint other

2.6

34.0

204

806

T90.5

ICD-10 Finland

Sequelae of intracranial injury

4.0

34.0

246

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

4.1

34.0

233

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

33.9

597

3529

SJB00

NOMESCO Finland

Fitting of removable appliance incl. patient instructions

2.8

33.9

168

602

SPA41

NOMESCO Finland

Precision impression for fixed dental prosthesis

2.9

33.9

161

564

WX704

NOMESCO Finland

Intubation

1.7

33.9

609

3622

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.8

33.8

170

614

R41.0

ICD-10 Finland

Disorientation, unspecified

2.7

33.7

179

665

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

33.6

296

1386

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

33.6

1730

13015

ZXD20

NOMESCO Finland

Day surgery

1.6

33.6

885

5808

R09.1

ICD-10 Finland

Pleurisy

2.9

33.5

159

557

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.9

33.4

258

UDM02

NOMESCO Finland

Sinoscopy

2.7

33.4

187

714

SPAT1104

SPAT

Monitoring of emergency patient

1.9

33.4

426

2281

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

33.3

342

1697

TAB20

NOMESCO Finland

Epidural puncture

4.2

33.3

215

X84

ICD-10 Finland

Intentional self-harm by unspecified means

10.3

33.3

D16

ICPC

Rectal bleeding

2.6

33.3

192

744

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

9.0

33.3

I20.09

ICD-10 Finland

Unstable angina

2.1

33.3

305

1450

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

4.6

33.3

170

K29.1

ICD-10 Finland

Other acute gastritis

3.6

33.3

108

300

EMB10

NOMESCO Finland

Tonsillectomy

1.8

33.3

477

2653

ZXD35

NOMESCO Finland

Usual procedure

2.4

33.3

225

941

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

33.2

743

4684

M01AH03

ATC

valdecoxib; oral

1.9

33.2

430

2315

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

33.1

418

2230

K04.00

ICD-10 Finland

Hyperemia of pulp

2.0

33.0

382

1979

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.9

33.0

453

2485

G72.9

ICD-10 Finland

Myopathy, unspecified

4.6

32.8

172

EBB15

NOMESCO Finland

Insertion of dental implant abutment

4.1

32.8

222

A92

ICPC

Allergy/allergic reaction NOS

2.2

32.7

269

1225

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.4

32.7

219

912

E23.03

ICD-10 Finland

Lack of ACTH

9.3

32.7

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

4.0

32.6

236

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.5

32.5

212

872

R31

ICD-10 Finland

Unspecified haematuria

1.8

32.5

559

3283

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

6.0

32.4

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

4.2

32.3

203

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

+∞

32.3

WZC30, ,

SPAT

1.7

32.3

609

3669

SPAT1059

SPAT

Spirometry at the office

2.0

32.3

337

1683

K03.66

ICD-10 Finland

Tooth plaque

1.7

32.3

566

3342

3AX01, ,

NOMESCO Finland

7.3

32.2

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

4.6

32.1

163

UJF92

NOMESCO Finland

Capsular endoscopy

2.6

32.1

181

694

SJD10

NOMESCO Finland

Placement of orthodontic arch wire

2.7

32.0

170

632

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.5

32.0

112

327

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

32.0

694

4340

WZB00, ,

SPAT

1.6

32.0

747

4759

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

31.9

278

1295

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

3.1

31.9

133

433

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

31.9

390

2060

WZC30

NOMESCO Finland

Teaching

1.5

31.9

1107

7715

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.3

31.8

234

1016

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

31.8

299

1436

L01BA01

ATC

methotrexate; systemic

2.2

31.6

280

1313

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

10.3

31.5

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

31.5

543

3191

F43.02

ICD-10 Finland

Acute stress reaction severe

7.9

31.5

L60.0

ICD-10 Finland

Ingrowing nail

2.0

31.5

362

1872

N02CD06

ATC

rimegepant; oral

4.4

31.4

178

K03.29

ICD-10 Finland

Erosion of teeth occupational

2.9

31.4

145

500

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.0

31.4

345

1755

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

6.6

31.4

AN1

Coronary angiography

1.8

31.4

532

3110

M01AE51

ATC

ibuprofen, combinations; systemic

3.3

31.3

121

376

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

7.1

31.3

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.6

31.3

188

744

N02CX04, ,

ATC

2.7

31.3

164

606

A07DA03

ATC

loperamide; oral

2.4

31.3

221

943

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

5.7

31.2

103

T90

ICPC

Diabetes non-insulin dependent

1.4

31.2

1438

10585

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

3.8

31.1

244

S97

ICPC

Chronic ulcer skin

2.0

31.1

373

1956

N05CD08

ATC

midazolam; nasal, systemic

2.8

31.1

158

574

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

31.0

565

3370

U29

ICPC

Urinary symptom/complaint other

2.4

31.0

224

965

N05AX16

ATC

brexpiprazole; oral

10.0

30.9

N39.3

ICD-10 Finland

Stress incontinence

1.7

30.8

554

3293

N64.4

ICD-10 Finland

Mastodynia

2.1

30.8

307

1508

S10

ICPC

Boil/carbuncle

1.9

30.7

412

2242

S82

ICPC

Naevus/mole

1.5

30.6

1055

7335

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.1

30.6

314

1558

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.6

30.6

179

699

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

30.5

3823

32837

R07

ICPC

Sneezing/nasal congestion

1.8

30.5

524

3074

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

30.5

779

5068

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

30.5

3374

28487

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4971

31994

2.45

318.28

7.5

6.9

1.22

mmol/l

0.50

4397

27649

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3480

19471

2.39

301.70

2.9

2.1

175.18

202.20

u/l

0.65

3340

18474

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6743

51442

2.93

280.39

6.1

4.2

10.57

11.18

mm/h

3.69

6413

48592

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4445

28242

2.28

278.32

2.5

2.0

97.33

97.54

pmol/l

0.11

2449

14847

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4463

28423

2.28

277.59

6.9

6.3

1.21

mmol/l

0.17

4138

26441

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3618

21185

2.29

275.04

3.6

2.5

55.48

63.79

u/l

1.45

3367

19744

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1603

6487

2.84

270.39

2.4

2.2

359.30

378.06

nmol/l

3.50

1475

6065

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5113

34835

2.29

264.73

6.6

6.3

9.63

10.94

umol/l

27.52

4874

33203

(3013115) Eosinophils [#/volume] in Blood

5310

36749

2.31

264.70

7.8

6.5

0.18

0.19

e9/l

1.95

4765

32440

(3006315) Basophils [#/volume] in Blood

5179

35537

2.29

262.57

7.5

6.3

0.04

e9/l

0.59

4567

30833

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6719

51810

2.81

261.00

10.0

7.9

74.91

77.20

u/l

5.64

6465

49366

(3001604) Monocytes [#/volume] in Blood

5164

35470

2.27

259.98

7.5

6.3

0.55

0.56

e9/l

3.36

4559

30790

(3019198) Lymphocytes [#/volume] in Blood

5243

36410

2.27

254.39

7.6

6.3

1.97

1.93

e9/l

0.95

4712

32371

(3024561) Albumin [Mass/volume] in Serum or Plasma

4455

29243

2.17

245.39

5.2

5.0

36.66

36.18

g/l

7.98

4186

27494

(3021960) Folate [Moles/volume] in Serum or Plasma

3078

17538

2.22

242.27

1.9

1.6

20.58

20.33

nmol/l

0.40

2677

15027

(3013650) Neutrophils [#/volume] in Blood by Automated count

5495

39750

2.21

228.50

10.6

9.4

3.96

4.02

e9/l

1.41

4901

34619

(3037522) Nuclear Ab [Titer] in Serum

2130

10647

2.36

226.82

1.6

1.4

442.41

563.27

titre

2.42

432

2336

(42870588) Differential panel, method unspecified - Blood

3649

22844

2.09

219.34

7.1

6.5

—

3.38

—

(3019069) Monocytes/Leukocytes in Blood

4715

32579

2.08

215.22

7.8

6.6

8.51

8.67

3.53

4436

30699

(3048689) Calprotectin [Mass/mass] in Stool

1999

9915

2.35

215.17

2.5

114.29

123.72

ug/g

0.60

1567

7995

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2954

17225

2.13

212.86

2.8

2.3

2.60

2.73

mg/l

2.39

2587

15017

(3031040) Bacteria [#/volume] in Urine by Automated count

5973

45296

2.24

211.42

7.1

4.2

1031.09

1576.54

e6/l

0.43

550

(3015377) Calcium [Moles/volume] in Serum or Plasma

3605

22701

2.07

210.80

3.1

3.5

2.35

2.36

mmol/l

0.18

3253

20810

(3022096) Basophils/Leukocytes in Blood

4691

32507

2.06

210.46

7.9

6.6

0.68

0.69

0.33

4418

30534

(3006504) Eosinophils/Leukocytes in Blood

4691

32522

2.06

210.00

7.7

6.5

2.74

2.84

2.33

4411

30609

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3008

17733

2.11

209.92

1.5

1.3

1.50

1.63

u/ml

0.20

787

5196

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2574

14304

2.18

209.34

1.5

1.3

27.10

30.70

iu/ml

0.43

718

4512

(3037467) Urinalysis macro (dipstick) panel - Urine

6175

47604

2.28

207.63

6.6

4.3

2215.17

2.59

—

(3002030) Lymphocytes/Leukocytes in Blood

4792

33593

2.06

206.61

7.7

6.4

29.31

28.55

5.72

4552

31966

(3013826) Glucose [Moles/volume] in Serum or Plasma

5347

39051

2.10

205.65

6.4

4.6

6.43

6.57

mmol/l

6.03

5103

36536

(3018010) Neutrophils/Leukocytes in Blood

4722

32981

2.05

204.99

7.6

6.3

56.19

56.85

3.99

4511

31629

(3019309) Folate [Moles/volume] in Red Blood Cells

1906

9456

2.33

203.62

1.9

1.7

1140.79

1168.73

nmol/l

0.71

1469

7292

(3028707) Methadone [Presence] in Urine by Screen method

407

780

5.44

201.62

2.9

2.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4624

32186

2.03

201.03

3.1

2.4

76.91

76.86

nmol/l

0.04

4255

29665

(3018418) pH of Serum or Plasma

3137

19187

2.04

194.53

4.4

4.2

7.40

0.10

2312

13688

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2398

13279

2.15

194.17

1.5

1.3

7.29

11.45

u/ml

1.59

903

5546

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3617

23391

1.99

190.44

3.8

3.2

30.78

33.83

u/l

1.40

3414

22114

(40768797) Stomach Pathology biopsy report

1865

9437

2.27

188.32

1.3

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2672

15658

2.06

184.25

2.2

1.7

0.90

1.13

mg/l

5.15

1995

12079

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6836

55993

2.48

183.99

6.2

4.4

14.56

14.63

pmol/l

1.58

6424

52124

(3032080) INR in Blood by Coagulation assay

4159

28502

1.95

181.99

12.7

12.3

1.15

1.20

inr

10.30

3483

23589

(3007164) IgA [Mass/volume] in Serum or Plasma

2598

15275

2.04

175.87

1.6

1.5

2.17

2.32

g/l

3.97

1565

9931

(3015736) pH of Urine

4244

29658

1.91

171.11

4.7

3.2

6.31

6.20

8.08

2429

16916

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3571

23736

1.91

166.34

5.1

3.3

41.60

67.50

ng/l

0.44

2243

14665

(3009261) Glucose [Presence] in Urine by Test strip

5081

38042

1.91

161.62

5.4

3.7

0.34

0.28

estimate

0.06

949

7579

(3035350) Ketones [Presence] in Urine by Test strip

5051

37766

1.91

161.08

5.4

3.7

2.84

3.79

estimate

0.18

970

7971

(3021601) Nitrite [Presence] in Urine by Test strip

5010

37377

1.90

160.67

5.4

3.6

0.00

estimate

0.27

961

7817

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4869

36163

1.88

156.33

4.1

3.1

98.85

105.91

ug/l

1.09

4569

34198

(3002582) Erythrocytes [#/volume] in Urine

3207

21063

1.87

150.77

4.4

3.1

34.12

74.47

e6/l

2.86

2578

15858

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2075

11987

1.99

142.33

4.9

3.5

141.18

482.29

ng/l

3.40

1373

8624

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2704

17093

1.88

141.18

3.2

3.0

812.68

1161.66

ng/l

4.65

2258

14547

(3018095) Leukocytes [#/volume] in Urine

3613

24973

1.81

141.09

5.3

3.7

65.24

91.92

e6/l

0.87

2691

17090

(3022948) Iron [Moles/volume] in Serum or Plasma

1947

11050

2.01

140.18

2.6

2.5

13.67

13.51

umol/l

0.41

1809

10345

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1530

7948

2.14

140.00

2.0

1.6

1.47

1.38

7.74

1345

7054

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1113

5095

2.37

138.26

2.6

2.4

17.03

21.03

au/ml

1.49

663

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1872

10604

2.00

134.79

3.3

3.4

0.83

0.82

mmol/l

3.03

1732

10018

(3026008) Bacteria identified in Urine by Culture

3040

20171

1.82

134.07

4.1

2.9

—

(3000850) Epithelial cells [#/volume] in Urine

2347

14368

1.89

134.04

3.3

2.6

6.12

6.51

e6/l

0.69

2171

13090

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1797

10055

2.01

133.85

2.3

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1800

10193

1.99

128.97

2.5

2.43

2.36

g/l

5.61

1665

9433

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1033

4726

2.36

127.90

1.4

1.3

41.70

50.30

au/ml

0.44

329

(3030467) Casts [#/volume] in Urine by Automated count

2774

18121

1.81

127.24

4.3

3.0

0.28

0.39

e6/l

3.07

2150

13080

(36304419) Bacteria [Presence] in Urine

2688

17405

1.82

126.88

4.1

2.9

0.23

241.87

estimate

0.62

(3015171) Extractable nuclear Ab [Units/volume] in Serum

748

2988

2.66

123.63

1.4

1.3

0.45

1.27

u/ml

2.30

247

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7375

65197

2.59

123.38

7.8

5.3

1.76

1.85

mu/l

8.30

6996

61216

(3011288) Drugs identified in Urine by Screen method Nominal

533

1783

3.13

122.23

3.0

2.1

—

(3019150) Specific gravity of Urine by Refractometry

2512

16086

1.82

121.99

5.4

3.8

1.02

1.31

kg/l

1.08

1782

10563

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

978

4528

2.32

117.23

1.8

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2549

16642

1.78

114.45

5.0

3.6

0.45

0.44

0.01

156

(3023368) Bacteria identified in Blood by Culture

2547

16636

1.78

114.13

5.1

4.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1637

9310

1.95

114.12

2.6

22.54

23.03

0.83

1514

8671

(3000570) Elastase.pancreatic [Mass/mass] in Stool

545

1924

2.97

113.59

1.5

1.4

315.14

275.58

ug/g

3.83

296

1116

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2056

12625

1.84

112.97

2.7

2.9

2.43

2.45

mmol/l

6.21

1806

11353

(3019550) Sodium [Moles/volume] in Serum or Plasma

7620

68938

3.02

112.71

24.6

15.3

139.65

139.70

mmol/l

0.85

7520

67564

(3023103) Potassium [Moles/volume] in Serum or Plasma

7622

69121

2.98

109.18

24.8

15.5

3.93

3.95

mmol/l

6.51

7516

67589

(3005322) IgE [Units/volume] in Serum or Plasma

1034

5068

2.19

107.46

1.5

1.3

168.55

186.83

u/ml

0.37

960

4724

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5938

49362

1.78

106.52

4.6

3.0

44.67

42.44

u/l

1.44

5643

46881

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1008

4910

2.20

106.33

3.0

3.6

4.41

4.54

pmol/l

4.11

881

4473

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2114

13336

1.79

105.01

1.8

1.7

50664895.30

27306869.59

pmol/l

0.85

1806

11327

(36660697) Celiac disease serology panel - Serum

1159

6025

2.08

103.12

1.3

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

621

2489

2.62

101.33

1.8

1.6

0.29

0.31

mg/l

0.33

232

1146

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1327

7301

1.98

100.61

2.1

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7608

69320

2.82

100.45

23.6

13.7

18.86

22.52

mg/l

24.38

6546

56241

(3007853) Bacteria identified in Skin by Aerobe culture

1398

7846

1.95

99.95

2.1

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

567

2202

2.69

98.48

2.6

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1823

11191

1.81

98.21

3.7

2.7

1.09

1.15

e6/l

0.25

1015

5835

(3026782) Osmolality of Urine

1929

12113

1.78

95.96

3.5

2.8

508.93

528.42

mosm/kgh2o

3.40

1725

10642

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1170

6277

2.01

94.87

3.2

2.4

35.36

38.27

u/l

0.45

987

5320

(3005719) IgG [Mass/volume] in Serum or Plasma

1054

5465

2.07

93.83

2.6

2.8

9.97

10.61

g/l

7.04

960

5069

(40758558) Short blood count panel - Blood

2893

20630

1.63

87.93

6.8

6.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

784

3736

2.22

86.44

3.5

3.4

5.24

5.13

kpa

2.96

739

3586

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1564

9494

1.80

86.02

2.2

2.1

28.87

29.44

4.02

1507

9229

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1223

6893

1.91

85.13

2.2

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

687

3123

2.31

84.77

3.2

3.3

1.97

1.81

mmol/l

0.62

521

2277

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

558

2320

2.51

83.99

1.8

1.20

g/l

0.12

525

2215

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3755

28706

1.58

83.96

5.3

3.5

0.26

0.31

estimate

0.08

826

6439

(3009343) pH of Capillary blood

762

3631

2.21

83.93

3.4

7.42

0.07

648

2984

(3045414) Leukocytes [Presence] in Urine

1180

6612

1.92

83.47

2.2

2.0

0.00

0.03

estimate

4.59

200

1444

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

544

2242

2.53

83.41

1.9

1.8

0.23

g/l

1.04

507

2137

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

456

1725

2.74

83.11

1.3

1.4

552.43

524.39

mg/l

0.14

431

1650

(3022145) Colonoscopy Study observation

1352

7925

1.85

83.09

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

420

1524

2.85

82.84

1.2

1.3

3.66

3.73

mmol/l

0.69

396

1445

(3014051) Protein [Presence] in Urine by Test strip

2902

20938

1.60

82.73

3.6

2.8

0.06

0.03

0.27

415

(3013139) Helicobacter pylori Ag [Presence] in Stool

961

5040

2.03

82.26

1.3

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1381

8189

1.83

81.62

5.2

5.9

1.04

mmol/l

0.24

1279

7646

(3002032) Base excess in Venous blood by calculation

1036

5600

1.98

81.35

4.4

3.9

2.15

1.80

mmol/l

2.66

923

4909

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

754

3625

2.19

81.12

1.2

1.1

0.90

2.56

u/ml

1.34

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1056

5753

1.96

81.04

4.4

3.9

5.93

5.80

kpa

3.86

1025

5612

(3023420) DNA double strand Ab [Units/volume] in Serum

682

3151

2.27

80.86

1.9

2.0

7.15

7.66

iu/ml

0.11

160

763

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1328

7820

1.84

80.15

2.9

2.7

5.78

7.67

umol/l

6.19

1117

6832

(3012544) pH of Venous blood

1065

5850

1.95

79.69

4.3

3.8

7.37

7.38

0.65

604

3299

(3029937) Albumin [Presence] in Urine by Test strip

2806

20237

1.59

79.26

5.7

3.8

0.00

estimate

3.90

919

7335

(3000494) Fungus identified in Specimen by Culture

1398

8404

1.80

78.69

1.7

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1624

10209

1.74

78.29

3.9

2.8

3.43

3.24

e6/l

0.24

809

4822

(3016879) Cocaine [Presence] in Urine

613

2744

2.34

78.21

2.6

1.7

—

(3042936) Bacteria identified in Isolate by Culture

1506

9278

1.77

77.89

2.3

2.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7220

65482

2.01

77.04

5.9

4.6

5.92

5.80

mmol/l

9.05

6756

61077

(3033658) Prothrombin time (PT) actual/Normal

2417

16989

1.60

75.18

4.8

3.8

95.56

92.54

8.20

2337

16596

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

406

1523

2.75

75.11

1.3

1.5

1055.14

1625.56

e6/l

0.39

325

1207

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

401

1498

2.76

74.78

1.3

1.4

16.70

31.90

e6/l

1.04

304

1113

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

943

5076

1.97

74.57

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

2976

22056

1.55

73.07

3.5

3.4

7.52

7.56

mmol/l

0.14

2534

18947

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

486

2020

2.50

73.01

2.2

218.94

637.87

ug/l

3.04

450

1910

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

535

2332

2.39

72.40

1.4

1.3

32.68

43.32

u/ml

0.21

156

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

455

1843

2.56

72.16

1.3

41.00

15.07

u/ml

—

(3019977) pH of Arterial blood

1160

6771

1.83

71.33

7.5

7.8

7.42

0.01

696

3637

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

120

195

6.23

70.46

2.1

3.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7076

64122

1.86

70.20

7.1

5.6

38.65

38.46

mmol/mol

1.03

6662

60756

(3014111) Lactate [Moles/volume] in Serum or Plasma

956

5272

1.92

70.14

6.4

8.0

1.30

mmol/l

0.04

933

5181

(3027801) Oxygen [Partial pressure] in Arterial blood

1155

6776

1.82

69.74

7.3

7.8

12.10

12.84

kpa

5.63

1113

6519

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1155

6779

1.82

69.63

7.3

7.8

5.13

5.07

kpa

1.28

1116

6521

(3026493) Urate [Moles/volume] in Serum or Plasma

2464

17719

1.56

68.01

2.5

320.00

329.37

umol/l

4.93

2165

15932

(3003396) Base excess in Arterial blood by calculation

1142

6726

1.81

67.94

7.3

7.7

1.48

0.82

mmol/l

7.09

930

5522

(3016502) Oxygen saturation in Arterial blood

1039

5964

1.85

67.14

7.4

8.2

95.51

95.85

0.76

1006

5756

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

900

4937

1.93

66.91

3.3

3.8

76.35

84.93

ng/l

2.29

779

4318

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1457

9237

1.71

66.90

2.4

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

628

3025

2.17

66.81

2.6

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

172

403

4.34

66.72

1.1

1.44

10.92

nmol/l

1.49

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

776

4062

2.01

66.08

1.1

—

(3017732) Neutrophils [#/volume] in Blood

1437

9106

1.70

66.00

3.5

3.1

4.42

4.35

e9/l

0.10

1203

8076

(3020630) Protein [Mass/volume] in Serum or Plasma

894

4941

1.91

64.88

2.4

2.7

66.74

66.84

g/l

0.16

813

4577

(3028300) Cannabinoids [Presence] in Urine

629

3066

2.14

64.86

2.6

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

3005

22748

1.51

64.67

2.8

2.3

—

(3019225) pH of Specimen

1010

5820

1.84

64.28

4.1

4.0

7.36

7.35

1.07

732

4133

(3024354) Oxygen [Partial pressure] in Venous blood

866

4757

1.92

63.98

3.8

3.3

4.59

4.57

kpa

0.08

841

4630

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4145

33549

1.49

63.92

3.2

2.7

—

estimate

—

(3027008) Opiates [Presence] in Urine

625

3058

2.13

63.80

2.6

1.6

—

(3008898) HLA-B27 [Presence]

600

2914

2.14

62.39

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

120

223

5.45

61.30

3.0

1.4

128.10

115.67

umol/l

0.17

115

(3004119) Hemoglobin [Mass/volume] in Venous blood

687

3554

2.02

60.26

3.6

3.3

131.36

129.65

g/l

1.28

663

3460

(3025941) Bacteria identified in Stool by Culture

745

3968

1.97

60.14

1.4

1.2

—

(3027944) Amphetamines [Presence] in Urine

612

3044

2.09

59.73

2.6

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

971

5650

1.82

59.59

8.0

8.6

123.25

121.37

g/l

2.16

954

5505

(40760892) CBC W Ordered Manual Differential panel - Blood

2319

16844

1.53

59.47

5.3

4.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1543

10225

1.63

58.85

2.5

2.0

—

(3027945) Reticulocytes/Erythrocytes in Blood

1107

6725

1.75

58.59

2.1

2.6

1.75

1.79

0.78

957

6052

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

999

5894

1.79

58.48

1.3

1.2

116.29

145.82

u/ml

1.37

336

2390

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

476

2166

2.27

58.07

1.4

1.3

8.63

8.01

u/ml

0.08

339

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

627

3187

2.05

57.66

2.6

2.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1135

6980

1.73

57.43

7.6

5.9

—

(4198724) Urine methamphetamine measurement

111

205

5.48

57.10

2.2

2.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

669

3497

2.00

56.88

1.8

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

777

4277

1.90

56.73

1.8

1.9

1.22

1.35

g/l

1.22

711

3975

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

473

2168

2.26

56.69

1.4

1.3

5.94

5.51

u/ml

0.05

210

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

440

1961

2.32

56.35

3.6

3.5

25.14

24.83

mmol/l

1.84

407

1816

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

498

2342

2.20

56.05

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

410

1778

2.38

55.91

1.3

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1021

6143

1.76

55.71

2.4

2.3

0.23

0.21

g/l

5.33

925

5774

(3023511) Choriogonadotropin [Units/volume] in Urine

397

1704

2.40

55.40

1.5

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

810

4554

1.87

55.32

2.7

2.2

5.54

7.25

ug/l

1.24

688

4037

(3021589) Normoblasts [#/volume] in Blood

3830

31065

1.44

55.02

13.3

10.7

0.00

e9/l

0.02

3135

25420

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

7161

66020

1.78

54.96

19.7

13.1

86.32

84.76

ml/min/173m2

8.87

6698

60617

(3022313) Gas panel - Capillary blood

522

2527

2.14

54.57

3.7

3.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

408

1788

2.35

54.31

1.3

1.1

—

(3000991) Gas panel - Venous blood

877

5087

1.81

54.09

7.7

9.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

218

694

3.20

54.03

4.7

5.3

351.99

367.10

umol/l

0.64

194

616

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

406

1780

2.35

53.98

1.3

29.59

44.23

u/ml

1.12

184

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

160

418

3.89

53.63

1.5

1.4

5.02

6.25

u/l

1.57

140

356

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

780

4390

1.86

52.99

3.1

2.8

122.69

163.21

ng/l

2.87

696

3983

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

587

3005

2.03

52.81

2.1

2.0

39.91

40.19

u/l

0.13

524

2732

(3030981) Hyaline casts [#/volume] in Urine by Automated count

882

5167

1.79

52.55

2.8

2.3

0.40

0.42

e6/l

0.06

829

4897

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

430

1956

2.27

52.44

1.4

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

545

2727

2.07

52.18

1.3

1.6

14.88

15.72

iu/ml

0.04

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

404

1794

2.32

52.14

1.3

2.90

2.79

u/ml

0.04

126

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1132

7129

1.68

52.08

3.6

4.5

228.18

241.51

u/l

2.76

1043

6795

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

270

994

2.78

51.68

1.3

0.55

3.49

nmol/l

0.80

256

968

(3008152) Bicarbonate [Moles/volume] in Arterial blood

658

3534

1.94

51.55

7.9

6.3

24.76

24.45

mmol/l

1.35

638

3361

(3026389) Candida sp identified in Specimen by Organism specific culture

287

1092

2.69

51.54

1.7

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

431

1978

2.25

51.44

2.5

2.8

25.16

24.75

mmol/l

1.59

422

1941

(3027273) Bicarbonate [Moles/volume] in Venous blood

505

2470

2.11

51.34

4.2

3.2

25.63

25.26

mmol/l

1.79

488

2387

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7733

73416

2.40

50.93

27.6

17.2

72.98

73.50

umol/l

0.95

7677

72604

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

397

1769

2.31

50.82

1.3

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

273

1027

2.72

50.13

1.3

0.14

0.29

nmol/l

1.92

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2295

17136

1.47

49.60

2.7

2.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

685

3779

1.89

49.42

1.1

70.00

189.04

titre

—

125

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

555

2859

2.01

48.98

1.6

10.26

13.77

u/ml

0.99

107

779

(3019420) Tryptase [Mass/volume] in Serum or Plasma

153

417

3.72

48.30

1.4

1.5

6.73

7.49

ug/l

0.20

146

375

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

213

727

2.98

46.86

1.1

—

89.29

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

248

920

2.75

46.79

1.7

1.6

407.56

350.65

mu/l

0.67

198

753

(3023520) Reticulocytes [#/volume] in Blood

851

5096

1.75

46.74

2.1

2.7

72.28

70.22

e9/l

0.92

617

3708

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

185

597

3.15

44.85

1.2

1.1

26.98

42.65

mg/l

11.94

153

502

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

672

3815

1.83

44.11

3.0

2.2

4453.03

6148.05

u/l

0.76

197

1655

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7692

73237

2.17

44.03

16.2

11.1

26.54

25.90

u/l

1.80

7538

71412

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

173

547

3.21

43.40

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

232

869

2.72

42.97

1.3

0.17

0.20

nmol/l

0.65

177

677

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

169

531

3.23

42.85

1.6

2.4

19.65

19.40

nmol/l

0.12

152

510

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

523

2765

1.95

42.73

4.9

3.7

49.55

47.62

1.05

518

2723

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

408

1974

2.12

42.57

1.3

1.2

3.85

4.04

0.16

333

(3047181) Lactate [Moles/volume] in Blood

382

1810

2.17

42.05

5.9

5.3

1.30

1.27

mmol/l

0.24

342

1585

(3009214) Lutropin [Units/volume] in Serum or Plasma

456

2312

2.03

41.96

1.4

10.28

10.56

u/l

0.16

356

1890

(3042517) Benzodiazepines panel - Urine

12.06

41.89

2.8

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

150

449

3.39

41.13

1.2

0.56

0.65

ratio

1.79

260

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

303

1318

2.35

40.97

1.5

1.3

28.28

27.13

u/l

0.22

244

1087

(3007930) Methemoglobin/Hemoglobin.total in Blood

467

2409

2.00

40.93

5.8

5.0

0.90

0.89

0.21

445

2262

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

176

584

3.06

40.72

1.1

203.08

252.87

mg/l

5.89

149

519

(3021387) Prolactin [Units/volume] in Serum or Plasma

554

3034

1.89

40.67

1.7

1.6

322.09

281.15

mu/l

1.52

492

2745

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

498

2633

1.95

40.65

5.7

4.7

1.66

1.60

0.78

477

2477

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

256

1037

2.52

40.48

1.3

1.2

10.18

13.31

u/ml

0.19

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

602

3405

1.83

39.88

8.3

9.9

16.31

16.04

1.53

587

3273

(3004616) Nuclear Ab [Presence] in Serum

234

921

2.59

39.28

1.4

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

446

2297

2.00

39.25

2.4

2.3

2.79

2.90

g/l

1.71

405

2112

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

192

685

2.85

39.03

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

597

3405

1.81

38.45

4.2

24.58

24.31

mmol/l

1.27

589

3379

(3017143) Hepatitis C virus Ab [Presence] in Serum

1320

9208

1.52

38.43

1.7

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

462

2431

1.96

38.21

2.4

2.3

7.21

7.40

g/l

1.92

421

2245

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

461

2426

1.96

38.12

2.4

2.3

3.54

3.70

g/l

1.87

421

2243

(4024509) Urine culture

560

3145

1.84

37.92

2.1

1.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

460

2427

1.95

37.74

2.4

2.3

4.29

4.25

g/l

0.56

420

2242

(3041096) Erythrocytes [Presence] in Urine by Automated

2660

21186

1.38

37.69

4.4

3.0

0.17

0.10

estimate

0.30

817

6275

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

408

2068

2.02

37.54

2.5

2.3

9.64

10.36

g/l

3.19

361

1867

(3045424) Erythrocytes [Presence] in Urine

588

3377

1.80

36.97

2.3

2.1

0.00

0.24

estimate

0.57

159

1161

(3020891) Body temperature

489

2652

1.90

36.93

5.5

3.9

36.95

36.92

°c

1.09

481

2633

(3020682) Albumin/Creatinine [Ratio] in Urine

2589

20603

1.38

36.61

4.0

4.1

6.04

8.51

mg/mmol

2.87

1524

12681

(3023183) Ammonium ion [Moles/volume] in Plasma

272

1189

2.33

36.37

2.4

3.0

32.20

34.75

umol/l

0.76

245

1087

(3024666) Lithium [Moles/volume] in Serum or Plasma

101

253

4.03

35.98

11.6

13.9

0.59

0.62

mmol/l

0.63

232

(46235355) HIV 1 and 2 tests - Meaningful Use set

2101

16203

1.40

35.69

2.1

2.0

—

(3012516) Albumin [Mass/volume] in Urine

2548

20310

1.37

35.37

3.5

34.58

46.21

mg/l

2.16

1549

12696

(3020779) Urea [Moles/volume] in Serum or Plasma

831

5307

1.63

35.36

6.8

7.6

8.25

9.28

mmol/l

4.24

774

5111

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

151

498

3.07

35.34

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

837

5360

1.63

35.21

2.2

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

454

2441

1.91

35.18

2.4

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

983

6564

1.57

34.64

2.4

1.9

—

(3022621) pH of Urine by Test strip

881

5738

1.60

34.54

3.0

2.5

6.13

6.10

0.58

577

3702

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

420

2224

1.94

34.06

2.1

1.9

1.59

2.05

ug/l

0.53

355

1987

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

399

2083

1.96

33.74

2.6

2.4

0.47

0.87

g/l

2.11

350

1814

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

832

5392

1.61

33.24

2.7

2.5

73.71

69.85

ml/min/173m2

1.99

351

2181

(3017446) Testosterone [Moles/volume] in Serum or Plasma

731

4590

1.65

33.18

2.7

2.2

11.85

12.71

nmol/l

1.82

653

4202

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

392

2054

1.96

32.79

1.1

4.91

6.98

eliau/ml

0.45

302

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

146

496

2.98

32.48

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

190

745

2.59

32.19

1.3

1.2

61.56

39.54

u/ml

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

348

1761

2.02

32.15

1.4

1.5

11.31

13.42

iu/ml

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

266

1215

2.23

32.08

1.5

1.6

0.67

0.76

g/l

0.79

202

928

(3028192) IgG subclass 2 [Mass/volume] in Serum

188

737

2.59

31.87

1.4

1.3

2.99

2.90

g/l

0.26

138

513

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

135

444

3.08

31.79

1.6

1.3

4.51

5.35

umol/l

1.80

119

400

(3024139) IgG subclass 3 [Mass/volume] in Serum

188

738

2.58

31.78

1.4

1.3

0.31

0.41

g/l

4.20

140

511

(3027135) IgG subclass 1 [Mass/volume] in Serum

188

738

2.58

31.78

1.4

1.3

6.12

6.70

g/l

2.07

139

513

(4062490) Immunoglobulin typing, IgG

184

715

2.61

31.76

1.5

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

179

4.39

31.22

1.3

121.51

128.17

nmol/l

0.14

128

(3028626) Oxygen [Partial pressure] in Capillary blood

289

1388

2.12

30.73

2.8

3.1

8.71

8.40

kpa

2.47

284

1356

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

248

3.78

30.42

1.4

1.3

107.31

108.89

0.21

223

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

408

2227

1.88

30.16

2.2

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

301

1479

2.08

30.14

1.5

1.4

—

(21494755) Public health laboratory ask at order entry panel

531

8623

0.59

30.11

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

267

3.63

29.55

1.4

1.2

0.31

0.29

g/l

1.04

219

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

314

1579

2.03

29.52

1.7

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

351

1838

1.95

29.41

1.5

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

892

6034

1.54

29.38

4.6

0.77

0.89

0.69

264

1683

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

324

1652

2.00

29.31

1.8

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

342

1783

1.96

29.03

2.7

2.3

0.01

0.02

g/l

0.78

316

1618

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

197

826

2.42

28.99

1.5

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

315

1602

2.01

28.70

2.8

2.4

0.00

g/l

-0.00

298

1515

(3020717) Zinc [Moles/volume] in Serum or Plasma

129

442

2.95

28.32

1.7

1.4

22.43

23.75

umol/l

0.19

122

409

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

147

542

2.74

28.18

1.4

1.3

1.09

1.66

u/ml

0.44

286

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

125

422

2.99

28.17

1.1

1.14

u/l

0.00

172

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

329

1714

1.96

27.98

2.7

2.3

0.00

g/l

0.50

298

1518

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

352

1877

1.92

27.94

2.2

2.1

10.27

11.45

mg/l

2.27

331

1768

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

180

737

2.48

27.91

2.0

2.1

19.92

26.17

mg/l

0.77

276

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

192

811

2.40

27.81

1.5

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

633

4003

1.63

27.79

7.2

8.5

25.30

24.80

mmol/l

2.92

627

3984

(3002179) Metamyelocytes/Leukocytes in Blood

852

5777

1.53

27.68

4.4

0.55

0.68

0.54

252

1615

(3021440) Promyelocytes/Leukocytes in Blood

854

5800

1.53

27.53

4.7

4.6

0.10

0.12

0.30

229

1453

(3008295) Osmolality of Serum or Plasma

162

640

2.56

27.09

1.6

1.4

279.89

277.16

mosm/kgh2o

0.80

132

486

(3006653) Thiamine [Moles/volume] in Blood

102

313

3.29

27.01

1.5

1.3

131.85

134.06

nmol/l

0.21

102

313

(3024522) Salmonella sp identified in Specimen by Organism specific culture

190

811

2.38

26.90

1.5

1.4

—

(3025159) Blasts/Leukocytes in Blood

862

5911

1.51

26.51

4.8

0.32

0.42

0.12

213

1409

(3052851) Hemolysis interference index of Serum or Plasma

322

1702

1.93

26.25

3.2

2.9

2.12

1.85

index

0.12

173

858

(3013005) Retinol [Moles/volume] in Serum or Plasma

102

319

3.23

26.20

2.2

1.6

2.10

1.91

umol/l

1.42

290

(1761868) Lipid panel - Serum or Plasma

2578

30677

0.77

26.17

3.2

2.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

335

1799

1.90

26.04

4.5

3.6

1.32

1.37

mmol/l

0.34

329

1760

(3048929) Epstein Barr virus Ab [Presence] in Serum

440

2574

1.75

25.85

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

256

1255

2.07

25.82

1.5

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

119

4.82

25.66

2.1

2.5

14.09

17.66

umol/l

1.61

119

(3004716) Salmonella sp identified in Stool by Organism specific culture

595

3779

1.62

25.62

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

600

3822

1.62

25.52

8.7

9.9

1.35

1.29

0.73

595

3796

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

255

3.48

25.52

1.1

38.18

284.47

ng/l

1.47

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

142

542

2.65

25.48

1.2

1.3

1.81

2.04

mmol/l

1.87

128

506

(3025468) Yersinia sp identified in Specimen by Organism specific culture

180

769

2.37

25.45

1.6

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

130

475

2.77

25.40

2.1

1.3

1.00

1.11

promille

0.40

102

374

(3003129) Base excess in Capillary blood by calculation

162

664

2.47

25.10

1.9

2.2

0.98

0.53

mmol/l

0.90

152

641

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

180

774

2.36

25.09

1.6

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7292

69587

1.52

25.07

6.3

5.3

2.79

mmol/l

0.02

6855

65748

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

553

3470

1.64

24.99

8.0

10.1

24.63

24.22

mmol/l

2.33

538

3413

(3005988) Vibrio sp identified in Specimen by Organism specific culture

180

776

2.35

24.94

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

186

814

2.32

24.90

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

186

814

2.32

24.90

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

186

814

2.32

24.90

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

186

814

2.32

24.90

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3421

29454

1.28

24.85

2.1

1.9

1.49

1.35

mmol/l

12.89

2936

25185

(3039162) Centromere protein B Ab [Units/volume] in Serum

211

977

2.19

24.67

1.3

59.70

60.29

u/ml

0.01

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

227

1085

2.12

24.49

1.7

1.4

—

(3000330) Specific gravity of Urine by Test strip

518

3215

1.65

24.44

3.6

3.1

1.02

ratio

1.22

473

2863

(3003181) Sodium [Moles/volume] in Urine

220

1042

2.14

24.30

1.6

1.3

57.54

63.44

mmol/l

1.42

181

827

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

167

706

2.39

24.20

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

286

3.24

23.90

2.4

1.6

30.77

29.05

umol/l

0.61

266

(3039000) Anion gap in Blood by calculation

247

1230

2.04

23.90

6.9

6.4

11.42

11.28

mmol/l

0.28

227

1092

(3018572) Chloride [Moles/volume] in Blood

247

1231

2.04

23.85

7.0

6.4

104.92

105.35

mmol/l

0.69

227

1094

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1065

7765

1.43

23.76

5.1

4.6

31.05

32.60

4.21

715

5358

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

100

328

3.07

23.76

1.4

1.2

61.25

64.37

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

288

3.22

23.64

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

138

542

2.57

23.41

1.3

1.2

52.14

45.35

u/ml

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

153

634

2.44

23.18

1.3

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

263

3.29

22.96

1.5

1.4

83.81

177.16

nmol/24h

0.84

263

(3011985) Renin [Units/volume] in Plasma

214

1031

2.11

22.64

1.8

1.5

74.85

69.33

mu/l

0.12

191

928

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

152

637

2.41

22.48

1.2

—

(3049717) Cytology report of Urine Cyto stain

334

1882

1.81

22.30

2.5

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

411

2460

1.71

22.24

2.4

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

202

959

2.13

22.21

1.4

325.43

361.26

pmol/l

0.46

176

839

(3000475) Leukocytes [#/volume] in Synovial fluid

295

1602

1.87

22.18

1.8

1.6

9128.24

12652.39

e6/l

0.89

208

1133

(3016244) Insulin [Units/volume] in Serum or Plasma

123

471

2.64

21.99

2.9

3.4

31.40

25.76

mu/l

0.52

115

450

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

344

1966

1.78

21.91

2.6

2.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

264

1389

1.93

21.86

2.1

1.8

180.65

199.82

pmol/l

2.02

250

1324

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

374

2192

1.74

21.83

1.8

2.1

49.81

6.22

iu/l

0.71

133

986

(3036489) Thrombin time

437

2672

1.67

21.83

2.3

2.0

20.75

20.81

0.04

367

2319

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

261

1369

1.94

21.81

1.2

1.1

19.22

14.85

au/ml

0.41

408

(3023323) Follitropin [Units/volume] in Serum or Plasma

732

5047

1.50

21.76

1.5

1.3

24.77

28.23

iu/l

2.16

617

4392

(3011412) CD3 cells [#/volume] in Blood

150

638

2.38

21.49

2.0

2.6

1471.06

1204.43

e6/l

2.16

126

556

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

443

2735

1.66

21.32

1.7

1.8

1.52

1.51

g/l

0.11

375

2369

(3034770) Mitochondria Ab [Titer] in Serum

358

2088

1.75

21.26

1.2

1.3

1576.00

900.14

titre

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5362

49226

1.27

21.10

3.8

3.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

145

614

2.39

20.99

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7199

68866

1.43

20.94

5.6

4.7

4.71

4.74

mmol/l

1.54

6812

65334

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

334

1918

1.77

20.94

3.3

3.4

27.07

52.74

mg/l

2.37

281

1632

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

145

615

2.38

20.91

1.2

—

(40768443) Skin Pathology biopsy report

499

3196

1.60

20.70

1.3

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

333

1919

1.77

20.63

3.3

3.4

55.91

81.21

mg/l

0.38

283

1629

(1616796) Gas panel - Central venous blood

250

1324

1.92

20.32

4.1

3.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

193

933

2.09

20.28

1.5

1.4

—

(3023410) Appearance of Cerebral spinal fluid

155

687

2.28

20.22

1.4

1.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

163

738

2.23

20.21

2.2

3.3

4.48

11.99

nmol/l

0.49

156

714

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

103

377

2.75

20.14

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

236

1230

1.95

20.12

1.5

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

225

1154

1.98

20.10

1.2

84.00

260.00

titre

—

(44813793) Dust mix specific IgE antibody measurement

132

547

2.44

20.06

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

116

453

2.58

19.97

1.8

2.7

521.13

520.23

e6/l

0.01

362

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

726

5082

1.47

19.96

3.8

3.7

1.22

1.23

mmol/l

1.98

638

4433

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

173

3.66

19.88

2.2

2.8

112.74

147.50

nmol/l

2.34

151

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

223

1146

1.97

19.81

1.2

164.00

396.47

titre

1.92

102

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

120

479

2.53

19.76

1.9

2.9

215.97

226.19

e6/l

0.26

402

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

186

896

2.10

19.74

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

476

3053

1.59

19.62

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

330

1926

1.74

19.57

2.1

1.8

41.49

41.57

nmol/l

0.02

324

1886

(40759836) Histone Ab [Presence] in Serum by Immunoblot

143

622

2.32

19.51

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6853

65159

1.35

19.46

4.6

4.0

1.39

1.26

mmol/l

26.84

6373

61068

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

138

595

2.34

19.22

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

359

2.75

19.16

1.6

1.7

2.99

5.43

nmol/l

0.53

294

(3029075) Extractable nuclear Ab panel - Serum

120

489

2.48

18.93

1.2

1.1

—

0.40

—

(3007566) Smooth muscle Ab [Titer] in Serum

351

2108

1.70

18.77

1.3

129.14

130.55

titre

0.01

218

(3033923) Metanephrine [Moles/time] in 24 hour Urine

109

4.33

18.68

1.1

0.60

0.72

umol/24h

0.79

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

213

1106

1.95

18.39

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

213

1106

1.95

18.39

1.4

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

135

588

2.32

18.38

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7150

68555

1.39

18.28

5.5

4.7

1.44

1.50

mmol/l

25.10

6719

64721

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

295

1706

1.76

18.08

3.2

4.35

3.01

ratio

0.33

163

962

(3006184) Hemoglobin [Mass/volume] in Capillary blood

262

1473

1.80

17.68

2.2

132.62

129.79

g/l

1.05

203

1136

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

119

500

2.40

17.60

1.9

2.3

—

(1002224) Polysomnography panel

549

3725

1.51

17.57

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

208

3.24

17.55

2.6

2.8

28.96

28.05

umol/l

0.19

151

(3010838) Calcium [Moles/time] in 24 hour Urine

239

1310

1.85

17.52

2.0

1.9

4.93

5.14

mmol/24h

0.50

222

1186

(3001186) Copper [Moles/volume] in Serum or Plasma

179

3.43

17.47

1.7

1.3

16.85

16.69

umol/l

0.10

155

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

229

3.12

17.46

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

202

1053

1.94

17.27

1.1

3.55

2.84

0.34

210

(3044941) Cell count panel - Synovial fluid

216

1153

1.90

17.20

1.6

1.4

—

(3010421) pH of Blood

327

1975

1.68

17.14

4.5

3.5

7.41

0.74

321

1957

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

432

2803

1.57

16.95

1.7

4.24

4.29

mg/l

0.03

357

2004

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

226

1232

1.86

16.87

1.7

1.6

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

358

2.62

16.56

2.2

1.9

143.20

140.22

0.12

337

(3018333) Ribosomal P Ab [Presence] in Serum

128

572

2.26

16.46

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

172

3.39

16.36

1.9

1.6

0.31

0.39

ug/l

0.98

126

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

313

1896

1.68

16.24

1.2

1.1

1.20

1.91

u/ml

1.36

168

946

(3003888) Timothy IgE Ab [Units/volume] in Serum

280

1650

1.72

16.09

1.1

4.40

4.97

u/ml

0.29

146

841

(1175426) CD3 cells/Lymphocytes in Blood

120

528

2.29

16.02

1.8

2.3

73.28

73.64

0.10

114

508

(3030313) Adrenal Ab [Titer] in Serum

4.94

15.90

1.1

—

38.57

titre

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

211

3.10

15.85

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

737

9899

0.72

15.80

2.0

1.9

3.47

3.43

ratio

0.45

549

7425

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6276

59385

1.26

15.60

26.7

16.7

13.54

13.50

2.25

6217

58602

(3038177) Helicobacter pylori Ab [Presence] in Serum

235

1329

1.79

15.59

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

835

6260

1.37

15.47

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

338

2122

1.62

15.26

3.0

2.4

176.01

187.08

1.51

318

2028

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

405

2.44

15.09

1.8

2.1

102.19

98.89

0.38

376

(40757494) Bilirubin.total [Moles/volume] in Blood

256

2.83

14.98

2.1

2.3

20.48

20.37

umol/l

—

(3007461) Platelets [#/volume] in Blood

7798

76367

1.70

14.83

34.6

20.9

260.65

257.65

e9/l

4.05

7702

75007

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

388

2534

1.56

14.82

1.6

2.03

10.93

iu/ml

0.58

450

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

236

2.90

14.79

1.2

1.1

91.91

92.42

0.04

108

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

282

1706

1.68

14.74

1.5

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1690

14042

1.26

14.67

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

534

7486

0.69

14.65

1.7

1.6

3.45

3.49

mmol/l

0.32

355

5019

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

356

2289

1.58

14.56

2.4

2.2

96.87

94.32

1.36

344

2204

(3024928) Oxygen saturation in Venous blood

252

1484

1.72

14.55

2.5

3.5

62.83

62.38

0.12

241

1449

(3035941) MCH [Entitic mass]

7798

76390

1.69

14.50

34.4

20.8

30.23

30.22

0.13

7748

75722

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

336

2133

1.60

14.50

2.9

2.5

3.46

3.61

g/l

1.13

312

2021

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7798

76391

1.69

14.49

34.5

20.8

90.82

90.76

0.63

7748

75722

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7798

76397

1.69

14.40

35.0

21.2

40.32

40.94

2.94

7747

75691

(3010813) Leukocytes [#/volume] in Blood

7799

76411

1.69

14.38

34.6

20.9

6.79

6.65

e9/l

5.63

7691

74832

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

251

1482

1.72

14.36

1.2

1.3

261.52

270.31

u/ml

0.21

151

934

(3026361) Erythrocytes [#/volume] in Blood

7798

76401

1.69

14.35

34.6

20.8

4.48

4.50

e12/l

1.92

7694

74854

(3000963) Hemoglobin [Mass/volume] in Blood

7798

76418

1.68

14.11

34.8

21.0

134.60

135.08

g/l

2.52

7748

75762

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

232

2.86

14.05

1.2

96.53

92.88

0.23

111

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

241

1420

1.72

13.91

6.3

5.7

1940.51

469.57

iu/ml

0.56

188

(3002079) Sodium [Moles/time] in 24 hour Urine

325

2.54

13.83

1.4

1.2

138.41

161.03

mmol/24h

1.92

325

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

101

3.88

13.47

1.1

0.03

u/ml

0.08

(3006270) Folate [Moles/volume] in Blood

111

510

2.19

13.43

1.2

1.1

385.92

385.76

nmol/l

0.00

101

454

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

149

3.30

13.36

1.1

—

(3016038) Potassium [Moles/volume] in Urine

373

2.40

13.34

1.4

1.2

33.53

34.41

mmol/l

0.15

326

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

208

1192

1.76

13.26

1.3

1.2

3.21

4.03

u/ml

0.86

101

541

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

120

573

2.11

13.18

1.1

284.35

289.36

mg/l

0.30

105

524

(3014271) Vancomycin [Susceptibility]

219

2.85

13.11

3.2

2.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

221

1294

1.73

13.07

2.4

2.0

0.87

0.84

nmol/l

0.25

185

1119

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

213

1235

1.74

13.04

1.3

1.2

3.88

3.44

u/ml

0.16

460

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

159

843

1.90

13.03

1.6

1.7

864.00

1232.73

titre

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

259

1584

1.66

13.02

1.1

0.57

1.11

u/ml

1.58

105

645

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

196

1112

1.78

12.94

2.3

2.7

916.33

1166.93

u/ml

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

243

2.73

12.92

1.3

1.2

122.53

111.08

0.93

223

(4094501) Cardiovascular stress test using bicycle ergometer

292

1844

1.61

12.91

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

337

2.45

12.85

1.3

1.2

201.01

298.19

u/l

1.33

311

(3023419) Bacteria identified in Sputum by Culture

151

791

1.93

12.84

2.3

2.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

131

653

2.02

12.84

2.0

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

190

1076

1.78

12.63

1.1

0.44

1.24

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.49

12.57

1.1

0.03

u/ml

0.07

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

311

2.49

12.53

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

422

2.27

12.50

1.4

1.5

29.54

18.44

u/ml

0.70

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

109

514

2.14

12.39

1.3

1.4

10.09

12.03

umol/l

3.33

102

492

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

245

1497

1.66

12.38

1.3

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

122

3.46

12.31

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

119

582

2.06

12.30

1.1

8.76

7.81

iu/ml

0.17

174

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

142

3.25

12.27

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

199

3322

0.59

12.27

1.1

0.55

0.61

ratio

0.98

392

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

184

1046

1.78

12.09

1.9

1.7

—

(3037121) Protein [Mass/volume] in Urine

322

2114

1.55

12.06

2.6

3.2

203.03

466.60

mg/l

3.84

114

912

(3016650) Hepatitis A virus Ab [Presence] in Serum

201

1174

1.73

12.02

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

21.29

11.99

1.6

4.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

114

555

2.07

11.94

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

202

1184

1.72

11.94

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

104

489

2.14

11.93

2.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

104

489

2.14

11.93

2.0

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

104

489

2.14

11.93

2.0

1.6

—

(3012501) Base excess in Blood by calculation

209

1238

1.71

11.89

5.2

3.8

2.73

2.44

mmol/l

0.78

137

829

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.67

11.86

1.1

1.0

—

(3013290) Carbon dioxide [Partial pressure] in Blood

209

1239

1.71

11.86

5.2

3.8

5.09

4.99

kpa

1.14

203

1220

(3027923) C peptide [Moles/volume] in Serum or Plasma

370

2.31

11.76

1.6

1.35

1.37

nmol/l

0.04

271

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

147

3.14

11.61

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

378

2589

1.48

11.59

1.3

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.82

11.41

1.6

1.07

2.45

mg/l

0.92

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

117

586

2.01

11.37

2.0

1.8

—

(4195642) Thrombophilia screening test

196

1156

1.71

11.35

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

208

1249

1.68

11.27

5.3

3.9

8.82

8.72

kpa

0.40

202

1229

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

4.44

11.17

1.1

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

4.44

11.17

1.1

1.0

0.21

0.25

u/ml

0.11

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

117

592

1.99

11.06

1.3

1.2

108.98

116.34

pmol/l

0.88

117

592

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

196

2.77

10.92

1.5

1.7

140.29

137.28

au/ml

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

435

2.15

10.85

1.2

—

(3037756) Immunofixation for Serum or Plasma

193

1151

1.69

10.75

1.8

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

206

2.68

10.49

1.4

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

823

6505

1.30

10.48

2.9

4.3

5.21

28.95

ug/l

3.45

634

5161

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

136

3.10

10.41

1.1

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

4.07

10.39

1.1

1.4

35.09

60.70

1.52

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

291

1934

1.52

10.36

1.2

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

244

1562

1.58

10.27

1.5

1.4

0.30

0.45

nmol/l

4.00

180

1215

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

18.78

10.24

1.8

1.9

387.00

340.63

nmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

117

3.26

10.23

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

221

1384

1.61

10.20

1.3

1.4

147.46

150.92

au/ml

0.14

393

(3042631) Mycobacterium sp identified in Specimen

140

774

1.82

10.17

2.6

2.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

269

1765

1.54

10.16

2.0

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

246

1582

1.57

10.16

1.2

1.1

0.97

1.80

u/ml

2.09

130

737

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

401

2.16

10.14

1.2

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.61

9.98

1.6

3.31

4.81

mg/l

0.42

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.61

9.98

1.6

2.16

1.59

mg/l

0.27

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.61

9.98

1.6

2.46

2.42

mg/l

0.01

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.61

9.98

1.6

0.84

1.12

mg/l

0.22

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.61

9.98

1.6

2.33

3.14

mg/l

0.22

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.61

9.98

1.6

0.75

1.57

mg/l

0.78

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.61

9.98

1.6

3.80

2.95

mg/l

0.24

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

200

2.66

9.98

1.3

1.2

31.80

18.96

—

(4015189) Microbial culture of sputum

124

3.16

9.98

2.9

2.0

—

(3000060) B lymphocytes [#/volume] in Blood

212

2.61

9.94

1.5

2.4

0.18

0.20

e9/l

0.16

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

167

2.83

9.92

8.3

3.2

5.13

4.94

kpa

0.49

167

(37208534) Antinuclear antibody arbitrary concentration in serum

224

2.56

9.90

1.1

—

(4268621) Lupus anticoagulant assay

152

870

1.76

9.84

2.4

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

168

2.81

9.82

8.3

3.2

11.38

10.29

kpa

0.94

168

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.37

9.78

1.1

1.82

1.91

iu/ml

0.10

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

244

2.47

9.72

1.5

13.43

14.96

pmol/l

1.36

209

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

106

544

1.96

9.68

3.1

4.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

105

539

1.96

9.59

2.6

2.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

424

2.09

9.57

1.6

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

112

590

1.91

9.48

2.8

2.2

106.17

105.39

mmol/l

0.79

112

581

(3041354) Potassium [Moles/volume] in Venous blood

112

590

1.91

9.48

2.8

2.2

3.92

4.03

mmol/l

2.08

112

581

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

243

2.44

9.32

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

202

2.58

9.27

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

202

2.58

9.27

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

202

2.58

9.27

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

202

2.58

9.27

1.2

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

146

2.89

9.25

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

166

993

1.69

9.21

1.1

1.44

1.49

g/l

1.25

149

906

(3024891) Influenza virus A+B Ag [Presence] in Specimen

286

1944

1.49

9.18

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

187

1155

1.63

9.17

1.1

123.17

117.10

1.59

175

1052

(3012494) Peanut IgE Ab [Units/volume] in Serum

215

2.52

9.16

1.0

1.1

0.27

3.24

u/ml

2.11

121

(3044927) Protein electrophoresis panel - Urine

103

536

1.93

9.06

1.4

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

367

2.14

9.04

1.4

47.14

52.96

titre

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

109

579

1.89

9.02

2.8

2.2

1.20

mmol/l

0.38

109

570

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

421

2.05

8.99

2.1

2.7

0.84

0.72

e9/l

1.10

408

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

349

2.16

8.94

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

128

2.98

8.85

1.7

1.4

1.19

1.17

mmol/l

0.65

128

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

274

2.31

8.84

1.8

2.1

8.88

9.66

mg/l

0.47

240

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.88

8.82

1.1

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

300

2.24

8.78

2.7

2.0

7.48

8.07

mmol/l

0.70

300

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

329

2.17

8.57

1.1

3.30

7.21

u/ml

0.81

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.47

8.35

2.0

1.7

1.37

1.32

umol/l

0.42

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.08

8.24

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

216

1421

1.53

8.14

1.1

2.10

4.01

u/ml

2.02

110

679

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1591

13849

1.19

8.07

5.3

5.0

2.10

2.51

ug/l

0.51

1438

12628

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

305

2.17

8.05

2.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

305

2.17

8.05

2.4

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

305

2.17

8.05

2.4

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

133

781

1.71

7.96

8.0

6.2

11.90

11.72

mg/l

0.17

123

735

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

353

2.08

7.94

1.4

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

148

2.71

7.90

1.2

87.33

80.32

0.36

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

6.07

7.82

1.4

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

127

2.84

7.77

1.7

1.2

67.29

70.24

mg/l

0.01

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

780

6353

1.25

7.74

4.3

3.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

151

926

1.64

7.69

1.3

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

111

626

1.78

7.66

3.0

3.6

55.95

57.45

0.33

546

(3032057) Clostridioides difficile [Presence] in Stool

112

2.95

7.63

1.7

1.9

—

(3028433) Virus identified in Specimen by Culture

192

2.46

7.62

1.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

306

2.13

7.59

2.5

1.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

100

548

1.84

7.59

1.2

60.00

226.94

titre

3.69

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

129

762

1.70

7.58

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

103

570

1.82

7.57

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

492

1.88

7.54

1.1

1.2

1.06

1.05

ratio

0.34

403

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

108

2.97

7.48

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.23

7.46

1.1

0.39

0.68

iu/ml

0.98

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

396

1.98

7.45

1.6

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

187

1219

1.55

7.39

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

391

1.98

7.36

1.6

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

476

1.88

7.30

1.2

1.1

—

(4211845) Urine protein measurement

331

2.06

7.30

3.5

2.9

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

149

2.63

7.27

1.2

69.83

71.61

0.07

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

269

2.16

7.06

2.8

3.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

146

2.61

7.01

1.1

—

(3006462) Nitrate [Presence] in Urine

304

2.08

6.94

3.7

3.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

8.25

6.81

1.9

1.1

291.24

675.24

nmol/l

1.25

(3027231) Wheat IgE Ab [Units/volume] in Serum

144

2.58

6.67

1.1

1.0

0.38

2.71

u/ml

0.73

126

(3023430) Cat dander IgE Ab [Units/volume] in Serum

199

1346

1.49

6.66

1.1

5.93

4.55

u/ml

0.19

588

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

118

707

1.68

6.63

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

145

2.56

6.59

1.2

542.40

307.70

pmol/l

0.73

107

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

128

785

1.64

6.58

1.1

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

419

5395

0.76

6.58

1.5

1.6

974.18

1001.17

mu/l

0.24

348

4572

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

120

725

1.67

6.54

1.2

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

213

2.26

6.53

2.8

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

213

2.26

6.53

2.8

2.1

—

(3036180) Methadone [Presence] in Urine

10.01

6.52

1.8

2.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

129

796

1.63

6.48

1.5

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

260

2.12

6.42

3.2

4.4

66.45

848.40

mg/l

0.49

186

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

404

1.89

6.41

1.4

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

267

2.11

6.40

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

215

2.24

6.39

3.0

2.1

—

(3007463) Buprenorphine [Presence] in Urine

9.24

6.28

2.2

9.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

117

712

1.65

6.23

1.2

56.09

57.33

u/l

0.10

630

(3033099) Centromere Ab [Titer] in Serum

174

2.36

6.19

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

481

1.80

6.19

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

168

2.39

6.18

1.3

1.1

—

(3017569) Oxygen content in Arterial blood

298

2.02

6.16

2.1

2.4

16.33

16.21

0.08

298

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

252

2.11

6.11

2.2

2.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

3.76

6.08

1.0

0.09

1.15

u/ml

0.82

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

558

1.73

6.07

1.1

—

(3017704) Immunofixation for Urine

300

2.01

6.06

1.9

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

531

1.74

5.97

3.4

2.5

21.78

27.16

mg/l

0.76

382

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

282

2.03

5.93

1.8

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

282

2.03

5.93

1.8

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.90

5.87

1.9

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

290

2.01

5.87

3.1

3.7

8.64

8.93

mg/l

0.11

237

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

192

1325

1.46

5.86

1.4

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

134

857

1.57

5.85

1.1

94.44

96.14

0.26

126

811

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.95

5.83

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

167

2.34

5.79

1.4

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

192

1329

1.46

5.78

5.2

4.0

—

(3024869) Neuronal Ab [Presence] in Serum

2.86

5.76

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

178

1215

1.48

5.75

1.1

1.0

0.41

0.25

u/ml

0.33

340

(3004451) EKG impression Narrative

335

1.92

5.70

1.4

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

386

1.85

5.64

2.7

42.06

42.84

0.14

212

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

365

1.87

5.62

1.1

1.0

281.27

340.62

ng/l

1.81

259

(3034274) Bile acid [Moles/volume] in Serum --fasting

188

1304

1.45

5.61

2.2

5.39

6.51

umol/l

0.76

140

955

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

268

2.02

5.60

2.8

2.4

45.58

51.75

umol/l

0.81

240

(3006571) Granulocytes/Leukocytes in Synovial fluid

119

749

1.60

5.58

1.7

1.6

48.40

55.28

0.96

471

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.40

5.57

1.1

1.39

1.68

umol/24h

1.55

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

146

2.40

5.52

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

411

1.81

5.50

1.4

1.8

98.14

101.76

ng/l

0.05

411

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

368

1.86

5.49

1.1

1.0

882.21

721.93

ng/l

1.63

252

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

135

2.45

5.43

1.0

0.02

5.42

u/ml

0.64

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

169

1157

1.47

5.41

1.1

3.11

3.50

eliau/ml

0.09

597

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

370

1.84

5.40

1.1

1.0

35.79

44.07

ng/l

1.35

258

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

119

757

1.58

5.35

3.5

5.4

157.25

97.58

u/ml

0.33

258

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6224

60376

1.14

5.34

29.0

17.1

332.39

332.29

g/l

0.38

6200

60055

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

272

2029

1.35

5.33

2.9

3.4

1.37

1.43

mg/l

0.71

240

1873

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

351

1.86

5.29

2.1

1.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

119

2.53

5.27

1.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

107

669

1.61

5.19

3.9

4.0

7.03

7.42

mmol/l

0.56

567

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

100

615

1.63

5.18

1.6

1.3

1.82

1.49

nmol/l

1.48

558

(3008757) Leukocyte morphology finding [Identifier] in Blood

577

1.65

5.17

3.5

4.1

—

(40761536) Microorganisms panel - Urine sediment

690

5796

1.21

5.13

5.7

3.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

163

1121

1.46

5.12

1.1

63.77

11358.39

iu/ml

0.64

237

(3020874) Milk IgE Ab [Units/volume] in Serum

592

1.63

4.94

1.1

1.23

1.65

u/ml

0.14

171

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

213

2.07

4.92

2.7

2.6

0.61

mmol/l

0.10

213

(3004809) Band form neutrophils/Leukocytes in Blood

145

984

1.48

4.89

3.0

3.6

1.15

1.58

0.92

128

891

(3051611) Lipemic interference index of Serum or Plasma

563

1.64

4.88

3.9

3.1

17.51

13.79

index

0.90

324

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

551

4553

1.23

4.84

2.6

3.4

23.76

54.35

u/ml

9.41

526

4409

(43055514) Macroprolactin [Presence] in Serum or Plasma

201

2.10

4.84

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

264

1.94

4.75

2.7

2.8

133.40

112.53

au/ml

0.15

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

372

1.78

4.73

1.1

23.90

19.52

u/l

0.21

335

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

108

2.51

4.69

1.3

1.5

0.41

0.30

nmol/l

0.47

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

373

1.78

4.69

1.1

74.76

75.93

u/l

0.04

337

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

155

1076

1.45

4.67

1.3

1.2

41.30

31.58

u/l

0.26

129

931

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.71

4.67

1.3

1.4

35.15

43.12

mg/l

0.50

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1247

11083

1.15

4.65

4.4

4.1

21.34

21.75

0.39

541

4998

(3007542) Rye IgE Ab [Units/volume] in Serum

3.11

4.63

1.0

1.1

0.10

0.79

u/ml

0.51

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

4.29

4.62

1.2

1.3

53.50

34.67

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.21

4.60

1.0

1.2

6.65

16.00

u/l

1.07

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.49

4.60

1.1

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

238

1787

1.34

4.53

3.5

3.2

0.34

0.35

iu/ml

0.22

136

961

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

381

3048

1.26

4.51

1.4

1.3

193.44

227.78

miu/ml

1.13

168

1511

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

223

2966

0.74

4.51

1.5

59.72

60.99

ug/l

0.17

183

2479

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

483

1.66

4.51

1.1

—

0.62

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

3.06

4.51

1.3

1.5

4.25

22.01

pmol/l

1.36

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

161

2.18

4.48

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

417

1.71

4.43

1.3

1.2

30.34

22.58

u/l

0.40

349

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

587

1.59

4.40

1.1

16.99

17.86

u/ml

0.06

259

(3047352) Trisomy 18 risk [Likelihood] in Fetus

166

2297

0.72

4.35

1.4

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

429

1.68

4.28

1.3

1.2

86.95

86.71

u/l

0.01

369

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

318

1.80

4.26

1.5

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

363

2911

1.26

4.23

2.0

1.9

—

30.85

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

172

2355

0.72

4.23

1.5

1.6

—

(3022475) Manganese [Moles/volume] in Blood

3.27

4.18

1.0

1.3

0.17

umol/l

0.03

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.81

4.18

1.3

1.1

0.04

0.05

u/ml

0.49

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

153

2.16

4.16

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

164

2256

0.72

4.16

1.4

1.5

1.30

1.26

0.48

117

1654

(3007916) DNA double strand Ab [Titer] in Serum

2.59

4.13

1.1

1.3

—

254.66

—

(3028717) Thiamine [Mass/volume] in Blood

103

2.43

4.12

1.3

1.2

57.48

63.68

ug/l

1.24

103

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

511

1.61

4.12

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.71

4.08

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

198

2634

0.75

4.05

1.5

1.6

—

(3024263) Appearance of Synovial fluid

318

1.77

3.97

2.0

1.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

5.56

3.97

1.2

2.00

2.89

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.60

3.96

1.0

0.01

0.12

u/ml

0.86

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.53

3.95

1.4

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

580

1.56

3.94

1.7

1.4

66160.10

94149.31

e6/l

0.23

398

(3025130) Human papilloma virus identified in Specimen

198

1480

1.35

3.94

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

211

0.24

3.93

1.4

1.2

28.60

69.73

ug/l

—

211

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

213

2786

0.76

3.88

1.4

1.5

0.98

0.94

ratio

0.63

112

1701

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

213

2786

0.76

3.88

1.4

1.5

1.18

1.20

ratio

0.14

112

1716

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

213

2778

0.76

3.80

1.4

1.5

1.12

1.15

ratio

0.16

112

1692

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

383

1.68

3.79

1.1

38.40

14.14

u/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

288

2280

1.27

3.78

2.8

3.6

175.27

1318.96

u/ml

1.46

246

1985

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

201

1.94

3.75

1.7

9.22

8.83

ug/l

0.25

201

(3019832) Treponema pallidum Ab [Presence] in Serum

1086

9701

1.14

3.75

1.9

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

105

709

1.49

3.73

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

182

1356

1.35

3.72

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.50

3.70

2.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

349

1.70

3.66

1.0

100.47

92.06

1.58

277

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.54

3.62

1.0

0.28

0.62

u/ml

0.40

(4034850) Laboratory test

262

2062

1.28

3.62

10.5

8.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.81

3.51

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

213

2745

0.77

3.51

1.4

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.87

3.48

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.70

3.48

1.3

7.31

6.26

mmol/l

—

(4146454) Self-monitoring of blood glucose

609

1.50

3.41

2.5

2.6

—

(3002256) Pathology report gross observation

1061

9532

1.13

3.35

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

101

2.28

3.35

1.0

1.1

0.40

0.81

u/ml

0.43

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.72

3.34

1.0

1.1

25.34

38.34

umol/24h

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.32

3.33

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

141

2.06

3.31

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.03

3.24

1.5

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

3.03

3.24

1.3

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.53

3.19

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

228

1.80

3.18

1.3

—

(44806420) Estimation of glomerular filtration rate

967

0.64

3.15

2.7

2.3

—

(21494814) CD8 cells/Lymphocytes in Specimen

259

1.74

3.12

2.3

2.2

30.71

30.39

0.05

259

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

4.50

3.11

1.0

2.66

1.94

u/ml

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

157

1182

1.33

3.06

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.38

3.05

1.3

—

(3001556) Androgen free Index in Serum or Plasma

2.35

2.98

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.54

2.95

1.0

0.07

0.57

u/ml

—

(3036670) Protein [Mass/volume] in Synovial fluid

162

1.92

2.93

1.4

1.2

36.05

39.16

g/l

0.37

(44806071) Cardiolipin IgM antibody measurement

108

2.13

2.89

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.21

2.89

1.0

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.59

2.87

1.4

1.5

14.81

18.58

pmol/l

0.29

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.59

2.87

1.0

0.02

0.09

u/ml

0.76

(3008536) Aspergillus sp Ab [Presence] in Serum

136

1.99

2.84

2.1

2.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

463

1.52

2.83

1.1

1728.10

1483.60

miu/ml

0.85

463

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.19

2.82

2.1

2.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

117

854

1.38

2.81

1.2

1.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

3.57

2.78

1.6

1.5

0.77

0.84

umol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

158

2045

0.77

2.77

1.5

55.55

59.33

ug/l

0.68

158

2045

(3036071) Salmonella sp Ab [Titer] in Serum

254

1.70

2.76

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

331

1.61

2.76

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

622

1.44

2.75

1.9

1.6

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

8.34

2.75

1.0

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

104

2.12

2.74

1.7

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.00

2.72

1.1

1.0

274.00

242.21

u/ml

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.71

1.2

—

mmol/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.43

2.70

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

469

1.50

2.69

1.6

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

234

1.71

2.67

1.8

2.0

263585.20

22829.67

u/ml

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

366

1.56

2.65

1.6

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.79

2.64

1.1

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.93

2.61

1.0

1.1

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1288

0.72

2.60

5.1

2.5

13.41

13.14

1.52

1271

(40762814) Titanium [Mass/volume] in Blood

2.25

2.60

2.1

2.5

3.57

3.86

ug/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

122

911

1.34

2.57

2.4

2.5

51.46

29.31

iu/ml

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

178

1.80

2.54

1.2

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

411

1.51

2.52

1.5

5.10

6.71

u/l

0.58

347

(3003329) Lymphocytes/Leukocytes in Synovial fluid

569

1.43

2.47

1.6

34.65

33.68

0.07

343

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.38

2.47

2.3

2.0

171.00

239.52

ug/l

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

160

1251

1.28

2.45

1.6

1.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

496

1.46

2.44

1.8

1.6

—

(3000012) Reticulocyte production index

108

799

1.36

2.44

2.0

0.90

0.02

530

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.24

2.43

1.5

1.2

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.13

2.43

1.1

1.0

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

162

1.79

2.30

1.3

49.82

41.88

0.48

112

(3034426) Prothrombin time (PT)

245

1.64

2.30

1.4

1.2

27.90

28.28

0.24

245

(3001218) Citrate [Mass/time] in 24 hour Urine

4.62

2.27

2.0

1.4

150.67

410.23

mg/24h

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

285

1.58

2.27

1.1

7.40

11.22

u/ml

0.72

196

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

162

1283

1.27

2.27

2.3

2.4

65.78

91.33

ug/min

0.58

784

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

216

1769

1.23

2.25

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

564

1.40

2.24

2.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.86

2.20

8.7

6.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

393

1.48

2.17

1.6

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.07

2.16

2.7

3.3

47.52

25.87

mg/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

118

1527

0.77

2.14

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

586

1.39

2.14

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

181

1.72

2.14

3.2

2.7

131.08

129.34

ng/l

0.01

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.62

2.14

1.0

—

39.06

—

(3041806) Other cells [#/volume] in Blood by Manual count

314

1.53

2.12

1.8

1.5

0.50

e9/l

0.03

314

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.14

2.08

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

540

1.39

2.05

1.1

1.2

88.00

81.91

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

254

1.58

2.02

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

352

1.48

1.98

1.7

1.5

—

(3016750) Collection duration of Urine

306

1.51

1.92

2.3

516.84

492.72

min

0.90

232

(3020876) Protein [Mass/time] in 24 hour Urine

749

1.31

1.86

2.8

2.3

0.72

1.33

g/24h

2.19

432

(3009871) Measles virus Ab [Titer] in Serum

333

1.47

1.85

1.6

3108.57

3614.22

titre

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.98

1.84

5.2

6.4

36.45

43.69

ug/min

0.24

(3012989) Citrate [Moles/time] in 24 hour Urine

3.53

1.83

2.0

1.5

1.58

1.95

mmol/24h

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.12

1.81

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

385

1.43

1.80

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

319

1.48

1.80

2.1

2.3

1.75

2.34

ug/l

0.86

276

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.57

1.80

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

330

1.46

1.73

2.1

2.2

3.29

3.04

ug/l

0.13

312

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.67

1.72

1.0

1.1

0.01

1.54

u/ml

—

(3036048) Francisella tularensis Ab [Titer] in Serum

163

1.66

1.70

1.1

—

205.00

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

586

1.33

1.69

1.1

1.0

0.83

1.19

u/ml

0.27

130

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

631

1.32

1.67

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

477

1.37

1.65

2.2

1.9

1.89

1.80

u/field

0.07

256

(3015076) Soybean IgE Ab [Units/volume] in Serum

555

1.34

1.64

1.1

1.0

0.35

0.98

u/ml

0.47

120

(3050129) First trimester maternal screen panel - Serum or Plasma

309

3527

0.87

1.61

1.5

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.87

1.60

1.4

1.3

5368.40

92.16

ng/l

—

(3046861) Legionella sp Ag [Presence] in Urine

2.50

1.59

1.1

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.95

1.59

1.0

0.01

1.15

u/ml

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

902

8376

1.09

1.57

3.2

3.0

0.60

0.75

ug/l

9.54

590

5039

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.20

1.56

2.5

1.6

46.09

45.84

umol/l

0.01

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

248

1.49

1.54

1.2

1.1

57.76

61.40

u/ml

0.11

243

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

145

1.66

1.53

2.5

2.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

727

0.73

1.53

1.5

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

407

1.38

1.53

1.7

1.48

1.75

u/ml

0.13

110

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

265

1.47

1.52

2.3

2.0

15.67

208.08

ug/min

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

100

1.80

1.52

1.3

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

391

1.38

1.51

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

408

1.38

1.51

1.6

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

185

1.57

1.50

1.1

19.07

35.55

iu/ml

1.87

185

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.86

1.50

1.0

258.80

268.25

nmol/l

—

(3033086) Enterovirus Ab [Titer] in Serum

2.86

1.50

1.2

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

123

1.71

1.50

1.0

93.86

73.91

ug/l

0.85

102

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.90

1.49

1.0

0.01

0.06

u/ml

—

(3000034) Microalbumin [Mass/volume] in Urine

540

1.32

1.46

3.3

2.8

25.94

55.20

mg/l

0.95

387

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.85

1.39

1.0

0.00

0.12

u/ml

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

111

1.71

1.38

2.0

1.8

—

(3012565) Volume of 24 hour Urine

347

1.39

1.38

1.8

2.1

2024.42

1950.71

0.23

319

(3020393) Adenovirus Ag [Presence] in Stool

2.00

1.38

1.1

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.00

1.38

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

158

1.58

1.37

1.7

1.8

20.14

41.63

u/l

0.81

150

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.61

1.36

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.94

1.36

1.6

1.2

22.32

35.36

mg/24h

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

526

0.70

1.35

1.8

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

306

1.41

1.35

1.7

1.5

1.45

3.15

1.36

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

143

1.61

1.34

1.5

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

143

1.61

1.34

1.5

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

143

1.61

1.34

1.5

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

187

1600

1.17

1.34

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

332

1.39

1.34

1.1

1.2

1111.11

1036.92

titre

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

307

1.40

1.33

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

187

1602

1.17

1.32

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

921

0.78

1.31

1.7

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.74

1.30

1.9

1.4

—

(4035726) Immunohistochemistry procedure

646

5970

1.09

1.30

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.35

1.29

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.89

1.28

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.94

1.27

1.3

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.82

1.25

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.00

1.23

1.6

1.3

377.33

329.24

umol/24h

—

(3020491) Glucose [Moles/volume] in Blood

504

1.29

1.21

1.8

2.0

6.34

6.43

mmol/l

0.11

367

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

314

1.37

1.19

1.9

1.6

1.75

3.48

u/field

1.00

225

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.75

1.18

1.4

1.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.11

1.18

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.88

1.17

1.1

1.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

291

1.38

1.15

42.2

39.8

7.64

7.33

ug/l

0.57

261

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.81

1.15

1.2

1.1

86.15

91.11

titre

0.09

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

1.14

0.0

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

153

0.52

1.13

5.8

6.2

8.63

8.20

—

153

(40761995) Spermatozoa Progressive [#/volume] in Semen

153

0.52

1.13

2.9

3.1

42.75

45.10

—

153

(3009677) Dengue virus Ab [Presence] in Serum

2.33

1.12

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

250

1.40

1.12

1.5

1.8

40.97

39.98

g/l

0.45

250

(3027456) Digoxin [Moles/volume] in Serum or Plasma

117

981

1.20

1.11

3.5

3.2

0.75

0.83

nmol/l

1.35

782

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

311

1.35

1.09

1.3

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

311

1.35

1.09

1.3

1.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.38

1.09

1.4

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

137

1.53

1.05

3.1

2.7

4.38

49.58

ug/l

0.83

137

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.79

1.04

2.3

2.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

419

1.29

1.04

1.2

1.3

160.53

165.43

pmol/l

0.08

419

(3003694) ABO and Rh group [Type] in Blood

2290

22203

1.04

1.00

1.5

1.6

—

(3004775) Volume in Urine collected for unspecified duration

414

1.28

0.98

2.4

2.3

659.98

634.46

0.19

282

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.17

0.98

2.8

5.4

—

(3052592) Norovirus Ag [Presence] in Stool

100

1.60

0.96

1.5

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.89

0.94

1.0

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.89

0.94

1.0

1.4

—

(40757373) Influenza virus identified in Isolate

110

1.55

0.90

1.4

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

224

2013

1.12

0.87

1.4

167.65

136.03

pmol/l

0.30

216

1961

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

169

1.42

0.87

1.2

9.52

10.17

pmol/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.82

0.85

1.0

—

(3024471) HLA-A [Type]

196

1.38

0.83

1.0

—

(3047189) Immunofixation for 24 hour Urine

257

1.32

0.82

2.6

1.7

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.74

0.82

5.3

6.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

436

4679

0.93

0.81

1.9

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.88

0.81

9.3

8.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.59

0.78

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.77

0.76

1.5

2.4

—

(3022229) Phosphate [Moles/volume] in Urine

1.77

0.76

1.7

2.2

11.83

16.69

mmol/l

—

(3024932) HLA-DR beta [Type]

193

1.35

0.73

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.00

0.72

1.4

1.2

—

(3044007) Cell count panel - Peritoneal fluid

195

0.67

0.72

3.2

1.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.58

0.71

2.3

2.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.53

0.68

2.0

2.3

0.33

0.80

u/field

—

(3043410) Blood group antigens tested for on Red Blood Cells

179

1.34

0.66

1.8

1.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.59

0.65

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.61

0.65

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

413

1.21

0.64

1.3

1.2

12.14

9.72

mm/h

0.65

413

(3023199) Leukocytes [#/volume] in Pleural fluid

644

1.17

0.63

1.4

5549.58

3472.40

e6/l

0.34

450

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.44

0.58

5.9

9.1

71.00

71.74

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

237

1.27

0.58

2.4

3.6

1.43

1.32

0.14

237

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

246

1.26

0.58

1.5

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.51

0.56

2.8

2.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

111

992

1.12

0.55

2.1

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

612

0.85

0.54

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

350

3307

1.06

0.50

1.6

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

316

1.20

0.49

6.9

5.9

75.67

11432.77

u/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

567

1.15

0.48

1.4

32673.93

60378.14

e6/l

0.61

302

(40768795) Lymph node Pathology biopsy report

743

0.87

0.48

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

474

1.16

0.48

1.3

1.4

913.86

352.15

u/l

0.60

455

(3034092) Cytoplasmic Ig cells/cells in Blood

1.40

0.48

23.8

7.9

0.21

0.19

0.13

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

137

1.31

0.47

1.1

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

365

0.82

0.47

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.46

0.46

1.0

—

(40765096) Chromosome analysis panel by Banding

191

1.26

0.46

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.38

0.45

1.5

1.3

6.40

7.23

mmol/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.56

0.42

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

131

1.30

0.42

1.3

1.2

10.38

301.45

ug/l

—

(40768800) Prostate Pathology biopsy report

827

0.89

0.41

1.2

—

(3022670) pH of Venous cord blood

0.00

0.41

0.0

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.41

0.0

6.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.41

0.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.36

0.41

1.0

1.1

—

(3006598) pH of Arterial cord blood

0.00

0.40

0.0

1.4

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.40

0.0

1.3

—

-0.56

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

492

1.14

0.40

5.9

7.2

11.36

61.25

ug/l

0.96

329

(3051387) C reactive protein [Mass/volume] in Capillary blood

147

1362

1.08

0.40

4.2

3.3

16.28

26.25

mg/l

5.31

924

(3013762) Body weight Measured

0.00

0.40

0.0

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

1.31

0.39

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

103

0.68

0.39

1.7

1.2

5.17

5.64

mmol/l

—

103

(3042733) HLA Ab [Presence] in Serum

206

1.21

0.37

4.9

5.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.35

0.37

1.0

1.1

—

(3019174) dRVVT (LA screen)

1.30

0.37

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.65

0.35

1.2

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.65

0.35

7.6

9.0

0.48

0.32

umol/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

190

0.79

0.35

1.3

1.8

1862.22

17826.99

e6/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

155

1450

1.07

0.35

1.5

1.3

4.26

3.71

ug/l

0.18

130

1292

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.30

0.33

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.35

0.32

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

266

1.17

0.32

1.0

—

(4212803) Bone marrow aspirate examination

1.35

0.31

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

286

1.15

0.31

33.3

28.3

114.85

115.43

ug/l

0.02

235

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

362

1.13

0.30

1.3

12.86

12.04

u/l

0.17

336

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

534

1.11

0.29

1.7

1.5

19.66

1741.94

pmol/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.25

0.29

1.3

1.4

—

(4281824) Cell count and differential, peritoneal fluid

867

0.92

0.28

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

162

0.80

0.28

1.3

1.5

11.42

12.08

g/l

—

121

(3020650) Glucose [Presence] in Urine

290

0.86

0.27

2.4

1.6

0.24

0.03

estimate

0.65

290

(3029396) Erythrocyte agglutination [Presence] in Blood

289

0.86

0.26

2.5

3.1

—

(4133840) Spirometry

178

1.18

0.26

1.3

1.2

—

(40768806) Pleura Pathology biopsy report

540

0.91

0.25

1.6

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.25

0.24

4.5

6.7

11.22

10.66

0.29

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

141

1339

1.05

0.23

2.2

3.6

148.77

667.44

u/ml

1.63

122

1217

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.25

0.22

1.0

1.9

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

0.26

—

(3045788) Cell count panel - Pleural fluid

536

1.08

0.21

1.4

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

28.18

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

585

0.92

0.21

1.6

1.4

29.08

37.00

nmol/l

1.00

533

(3012441) Differential panel - Pleural fluid

537

1.08

0.20

1.5

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.20

0.0

1.2

—

64.24

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

128

1.17

0.18

8.2

7.3

8.25

5.49

kpa

0.89

128

(40758292) HTLV I+II Ab panel - Serum

138

1.16

0.17

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

111

1.17

0.15

1.2

1.3

1.69

1.77

mmol/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.76

0.15

1.8

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

713

1.05

0.14

1.4

1.5

32.27

32.81

g/l

0.15

651

(21494434) Karyotype in Bone marrow

529

1.06

0.13

1.3

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.15

0.10

4.6

6.4

7.94

8.07

mmol/l

0.05

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.06

0.09

14.8

2.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.09

0.08

1.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

0.81

0.08

1.2

1.4

—

0.20

—

(3044009) aPTT.lupus sensitive (LA screen)

1.09

0.08

1.1

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

117

1.11

0.08

2.6

2.5

6.34

7.51

mmol/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

156

1.09

0.08

1.3

—

(3045142) Bone marrow Pathology biopsy report

688

1.03

0.07

1.3

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

129

1.09

0.05

1.0

1.1

5.04

7.16

u/ml

0.70

129

(3035880) pH of Pleural fluid

268

1.04

0.04

1.1

1.4

7.41

0.00

179

(40768793) Breast Pathology biopsy report

202

2043

0.99

0.04

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

107

0.93

0.02

1.1

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

113

1.06

0.01

1.8

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

127

0.94

0.01

1.3

1.1

—

(40768446) Kidney Pathology biopsy report

257

0.97

0.01

2.0

1.6

—

(40768441) Liver Pathology biopsy report

523

1.01

0.01

1.5

1.4

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

139.83

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

112

1120

1.00

-0.00

1.5

1.4

6.80

6.99

mmol/l

0.33

1006

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.01

-0.00

8.7

12.0

8.92

5.51

mmol/l

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

0.03

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3002022) Protein C Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

59.20

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

41.50

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.12

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

79.33

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

2.8

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

3.0

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.0

—

5.14

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SOMATOFORM and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_SOMATOFORM	1.294 [1.17, 1.43]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.045

During the follow-up period (1.1.1998 — 31.12.2019), 2265 out of 23873 females with F5_SOMATOFORM died.

Males

Parameter	HR [95% CI]	p-value
F5_SOMATOFORM	1.275 [1.15, 1.42]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 1449 out of 12088 males with F5_SOMATOFORM died.

Mortality risk

Mortality risk for people of age

years, who have F5_SOMATOFORM.

N-year risk	Females	Males
1	0.128%	0.309%
5	0.621%	1.541%
10	1.678%	3.665%
15	3.135%	7.101%
20	5.464%	11.834%

Relationships between endpoints

↥

Index endpoint: F5_SOMATOFORM – Somatoform disorder

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Somatoform disorder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints